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GLOSSARY 
 
Telomere: a region of repetitive DNA at the end of linear 
chromosomes, which protects the end from degradation or loss. 
Telomerase: "ribonucleoprotein complex" composed of a protein 
component, a reverse transcriptase, TERT, and an RNA primer 
sequence, TERC.  It adds new telomeric sequences at 
chromosomes terminus counterbalancing telomere shortening. 
ALT: alternative recombination-based mechanism of telomere 
lengthening. It could be activated in telomerase negative cells. 
TIFs (Telomere Dysfunction-Induced Foci):  Dysfunctional, 
uncapped telomeres, that activate a strong DNA damage response 
and become associated with DNA damage response factors, such 
as 53BP1, γ-H2AX, Rad17, ATM, and Mre11.  
DNA damage response: A cascade of processes induced by the cell 
cycle regulator phosphoprotein p53, or an equivalent protein, in 
response to the detection of DNA damage. 
DNA strand break: it involves one or more disruptions of the 
covalent linkages among phosphodeoxyribose moieties within the 
sugar-phosphate backbone in one (single stranded (ss) breaks) or in 
both (double stranded (ds) breaks strands of a DNA molecule). It 
can be induced both by exogenous factors and endogenous 
processes.  
Shelterin: six-protein complex that enables mammalian cells to 
distinguish their natural chromosome ends from DNA breaks, 
represses DNA repair reactions, and regulates telomerase-based 
telomere maintenance. The components of shelterin specifically 
localize to telomeres; they are abundant at telomeres throughout 
the cell cycle; and they do not function elsewhere in the nucleus. Is 
formed by TRF2, TRF1, POT1, TIN2, TPP1 and Rap1. 
Replication fork: the branch-point structure that forms during DNA 
replication between the two template DNA strands where nascent 
DNA synthesis is ongoing. Fork progression is mediated by the 
action of DNA helicases that unwind the DNA and facilitate the 
movement of the DNA synthesis machinery. 
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Fragile site: a specific heritable site on a chromosome that is prone 
to form gap and breaks when the cell is exposed to partial 
replication stresses.  
Nuclear periphery: term that generally refers to the nuclear-
membrane bilayer, its associated proteins and the embedded 
nuclear-pore complexes. 
Nuclear lamina: The proteinacious meshwork that underlies the 
inner nuclear membrane. 
Lamins: are rod-shaped proteins of the intermediate filament class. 
They consist of a head and tail domain that flanks a conserved 
alpha-helical rod domain. Lamins form parallel homo- and 
probably heterodimers which, in turn, can polymerize in a head-to-
tail fashion. These linear polymers are thought to associate 
laterally into 10-nm lamin fibres, which form the fibrous lamina 
meshwork in the nuclear periphery. Mutations in their encoding 
genes are associated to different diseases collectively named 
laminopathies. 
Laminopathies: A group of diseases that include premature ageing 
syndromes and certain types of muscular dystrophies and are 
associated with mutations in genes encoding lamins. 
Cell senescence: the phenomenon in which replicatively dividing 
cells enter a non-dividing or quiescent phase that is accompanied 
by changes in gene transcription and metabolism. 
Progeroid disease: A genetic disorder in which various tissues, 
organs or systems of the human body appear to age prematurely. 
These diseases are often called segmental progeroid diseases 
because they do not fully recapitulate normal ageing. A common 
feature of such diseases is genomic instability. 
E2: An enzyme that forms a thioester bond with ubiquitin (Ub) 
following transfer from an E1 enzyme. E2 enzymes are referred to 
as Ub or Ubl-conjugating enzymes because they can conjugate the 
Ub protein directly to a substrate. However, E2 enzymes often 
require E3 ligases for proper function. 
PCNA (Proliferating cell nuclear antigen): ring-shaped molecule 
encircling DNA. It slides bidirectionally along DNA to 
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constitutively monitor genomic integrity. Following DNA damage, 
ubiquitylation of PCNA is essential for the recruitment of damage-
tolerant DNA polymerases, allowing translesion synthesis. 
Fluorescence in situ hybridization (FISH): A technique whereby a 
fluorescently labelled DNA probe is used to detect a particular 
chromosomal region by fluorescence microscopy. 
Chromatin immunoprecipitation (ChIP): A technique that involves 
crosslinking methods and is used to identify pieces of DNA or 
chromatin that contact a protein of interest in vivo. 
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SUMMARY 
 
Telomeres are nucleoprotein structures that protect the ends of 
linear chromosomes. They are composed of long tracts of 
TTAGGG repeats, telomere specific proteins that form the 
shelterin complex and several telomere accessory proteins that co-
operate to telomere metabolism.  Proper telomere maintenance is a 
crucial process to protect the genome against instability and 
telomere dysfunction has been linked to tumorigenesis and 
premature aging. AKTIP gene is the human homologue of 
Drosophila peo, a gene that was recently linked to telomere 
metabolism.  
The aim of this study was to understand if AKTIP could have a 
role in human telomere metabolism, in analogy with the telomeric 
function of its homologous in fly. For this purpose we have 
analyzed the phenotype of human cells in which AKTIP expression 
was downregulated by RNA interference. In human primary cells 
AKTIP downregulation triggered the reduction of the mitotic 
index, proliferation impairment and premature senescence. AKTIP 
reduction induced a strong DNA damage response proved by the 
accumulation of the phosphorylated form of proteins involved in 
DNA damage sensing and signaling such as ATM, p53 and Chk1, 
by the accumulation of p21 mRNA and by the formation of foci 
containing DNA damage response proteins. About half of these 
foci were located at telomeres (TIFs) indicating the presence of 
dysfunctional telomeres in AKTIP knocked down cells. These data 
were consistent with the accumulation of aberrant telomeres in 
MEFs p53-/- observed following the downregulation of murine 
homologue of AKTIP (named Ft1). AKTIP involvement in 
telomere metabolism was further suggested by its interaction with 
telomeric repeats observed by ChIP analysis. Altogether, these 
findings indicate that AKTIP takes part in telomere maintenance. 
Interestingly, immunostaining assays showed that AKTIP is not a 
stable component of telomeres but was found located in the 
nucleus, mainly at nuclear rim. This particular localization, in 
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addition with the telomeric role outlined for AKTIP, suggest that 
AKTIP is a telomeric nonshelterin protein. Consistent with this 
hypothesis, we observed that Ft1 downregulation caused the 
formation of chromosomal aberrations in addition to telomeric 
abnormalities, indicating that AKTIP/Ft1 plays a role not only in 
telomere maintenance but also in the overall genomic stability, 
possibly contributing to DNA replication. Indeed, the most 
prominent telomeric aberration observed in Ft1 downregulated 
MEFs was the formation of multiple telomeric signals at the ends 
of chromosomes, also known as fragile telomeres, indicative of 
replication impairment. In addition, AKTIP downregulation was 
found to induce an S-phase block of cell cycle progression and a 
strong reduction of PCNA positive cells in primary fibroblasts, 
along with an increased sensitivity to drugs that impair DNA 
replication, as aphidicolin.  
Collectively, these data demonstrate that AKTIP is a protein 
needed for proper DNA maintenance in mammalian cells. In the 
telomeric context AKTIP likely is a telomeric accessory protein, 
rather than a shelterin-like protein, because it’s conserved in fly, 
differently from shelterin proteins, has a role in telomere 
maintenance but is not stably located at telomeres. AKTIP, in 
addition to its telomeric function, seems to have a more general 
role in cellular metabolism, as all the other telomeric nonshelterin 
proteins. In particular our data indicate that AKTIP could be 
involved in DNA replication.  
Considering all the collected data together, our current hypothesis 
is that AKTIP plays a role in replication of complex DNA 
structures, including telomeric repeats. Its downregulation could 
impair the replication fork progression through these DNA regions 
leading to chromosomal aberrations, DNA damage response and 
cell cycle alterations, the most prominent phenotypic traits of 
AKTIP knocked down cells.  
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INTRODUCTION 
 
TELOMERES: structure and function 
 
The genetic information of eukaryotes is organized on linear 
chromosomes located in the nucleus. Chromosomes linear nature 
poses two main challenges for the cell: the so-called end protection 
problem, that deals with the need to distinguish the natural 
chromosomal ends from double strand (ds) break to avoid 
deleterious nucleolytic attack and their recruitment in harmful 
DNA repair reactions, and the so-called end replication problem 
concerning the inability of DNA polymerase machinery to 
complete the replication of lagging strand, leading to progressive 
erosion of chromosomes ends. Telomeres are the evolutionary 
answer to both this problems: they are nucleoprotein structures 
located at the ends of linear chromosomes and either facilitate 
replication of the chromosomes ends and protect them against 
erosion and recognition by DNA damage machinery (Chan, 2010; 
de Lange, 2009). 
Telomeric DNA of most eukaryotes is composed of ds short 
tandem repeats in which the strand running 5’-3’ from the 
centromere towards the chromosome end is generally guanine-rich 
and cytosine-devoid and for this G/C composition, the two strands 
of telomeric DNA are called G- and C-strand. The length of this 
duplex telomeric DNA per chromosomes varies enormously from 
organism to organism ranging from 300 bp of  S. Cerevisiae and S. 
Pombe to 10-15 kb in human (Samassekou, 2010) and 20Kb or 
more for laboratory mice and rats (Paeschke, 2010; Palm, 2008). In 
mammals, like in most eukaryotes, the telomeric DNA is 
constituted by tandem repeats of TTTAGG examer. The actual 
ends of telomeres is not blunt, but is characterized by the presence 
of a single stranded 3’-protrusion’s of the G-strand, called G-tails 
or G- or 3’-overhang; this is a conserved feature of eukaryotic 
telomere structure and is essential for telomere function. Also G-
strand protrusion length is highly different among eukaryotes and 
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in mammalian telomeres its length varies between 50-150 nt, 
which is considerably longer protrusion of most other eukaryotes 
(McElligott, 1997; Wellinger, 1997). It has not yet been fully 
elucidated how this overhang can be generated but its formation is 
likely linked to an active and highly regulated post-replicative 5’-
3’ exonucleolytic resection of the C-strand. Consistent with this 
scenario, the 5’ end of human telomeres, located on C-strand, is 
accurately defined and predominantly ends with the sequence 
ATC-5’, while the last base of the 3’ end, located in the G-
overhang, is variable in telomerase negative cells (Sfeir, 2005; 
Palm, 2008). This overhang is important for the creation of the t-
loop, a lariat structure that contributes to ends protection (Figure 1) 
(de Lange, 2004). Moreover it provides the substrate for 
telomerase, a specialized enzyme able to add telomeric repeats to 
chromosomes ends after cell division (Chan, 2002).  
Moving from chromosomes end to centromere in most eukaryotes 
subtelomeric sequences are present in the subterminal region 
adjacent to telomere. In higher eukaryotes these regions are 
enriched of repetitive DNA and typically comprise subdomanis 
forming a gradient progressing from telomeric repeats at the distal 
end of subtelomeres to variant repeats and finally degenerated 
repeats in proximal domain (Louis, 2005). The subtelomeres are 
enriched in segmentally duplicated DNA compared to genome as 
whole and in short direct and inverted repeats and AT-rich regions. 
These DNA sequences are frequently found at more than one 
telomere in an organism, but are not conserved between different 
species (Louis, 2005). Moreover, in mammals, whereas telomeres 
don’t contain genes at all, subtelomeres are gene poor (Blasco, 
2007). Growing evidences suggest that subtelomeric regions could 
have a role in telomere length regulation (McCord, 2008).  
In yeast only subtelomeric repeats contain nucleosomes, whereas 
both mammalian telomeres and subtelomeres contain nucleosomes 
(Figure 1) (Blasco, 2007). These show a slightly altered spacing 
compared with non-telomeric chromatin: telomeric nucleosomes 
are characterized by an unusual repeat length that is about 20-40 bp 
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shorter than bulk nucleosomes spacing and by a low content of 
linker histone H1 (Pisano, 2008).  
A highly conserved feature of telomeric DNA is its 
heterochromatic status. The first heterochromatic attribute 
described for telomeric regions is their ability to silence nearby 
genes, a phenomenon known as “telomere position effect” (TPE). 
It was described first in D. Melanogaster and later reported also in 
yeast and mammalian telomeres (Blasco, 2007). Consistent with 
the observation of TPE in mammalian cells, many marks that are 
usually found in heterochromatin can be found in mammalian 
telomeres. In particular trimethylation of H3K9 and H4K20 have 
been identified at mammalian telomeric and subtelomeric domains; 
for H3K9 this modification is carried out by SUV39H1-H2 
(Garcia-Cao, 2004) whereas H4K20 trimethylation is carried out 
by SUV4-20H1-H2 (Benetti, Gonzalo, 2007). Moreover human 
and mouse telomeres and subtelomeres can also be found enriched 
in HP1, that is recruited at telomeres through its affinity for 
trimethylated H3K9 and it’s important for chromatin compaction 
(Blasco, 2007). Mammalian telomeres and subtelomeres are also 
characterized by low levels of acetylated H3 and H4 (Benetti, 
Garcia-Cao, 2007). In contrast to budding yeast that lacks DNA 
methylation, mammalian subtelomeric sequences are heavily 
methylated, whereas telomeric repeats cannot be methylated 
because they lack CpG sequences that are the substrates for 
mammalian methyltransferase (Gonzalo, 2006). Increasing 
evidences suggest that there is an important role for histones and 
DNA methylation in regulating mammalian telomere length and 
integrity, and an important role of telomere length in regulating the 
assembly of heterochromatin domains at telomeres (Benetti, 
Garcia-Cao, 2007; Garcia-Cao, 2004; Blasco, 2007; Schoeftner, 
2009). Epigenetic marks at telomeric and subtelomeric chromatin 
are essentials to repress and regulate recombination events 
(Gonzalo, 2006; Blasco, 2007; Schoeftner, 2009). However, 
mammalian telomeres don’t exhibit all the features previously 
described for constitutive heterochromatin, for example human 
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telomeric DNA is not late replicating in contrast to yeast telomeres 
or mammalian pericentric heterochromatin (Wright, 1999; Arnoult, 
2010).  
Considering their compact heterochromatic structure, telomeres 
were not regarded to be permissive for transcription; nevertheless 
recently reports showed that telomeric C-strand is frequently 
transcribed by RNA polymerase II, giving rise to UUAGGG-
repeats containing non-coding RNAs named TERRA or TelRNA 
(Azzalin, 2007; Schoeftner, 2008). Transcripts containing 
telomeric repeats have been described in mice, humans, and yeast 
(Schoeftner, 2009) and also in Drosophila, telomeres lengthen is 
dependent on transcription of telomeric regions, suggesting that 
transcription could be a universal process occurring at the ends of 
linear eukaryotic chromosomes (Schoeftner, 2009). Currently it’s 
not clear which is the function of TERRA molecules but they are 
proposed as negative regulators of telomeres length and in this 
context it has been proposed that they could act inhibiting 
telomerase or influencing semi-conservative telomeres replication 
or their chromatin structures (Schoeftner, 2009; Feuerhahn, 2010). 
The structure of telomeric DNA, although is generally conserved 
from yeast to human, is not universal and some exceptions exist. 
One of these is represented by Drosophila Melanogaster in which 
telomeres consist of tandem array of sequences produced by 
successive transposition of specialized non LTR-retrotrasposons 
(see below for detailed description) (Louis, 2005; Blasco, 2007).  
Mammalian telomeres are also constituted by a complex of six 
proteins called shelterin complex (described in details in the next 
sections) that has a major role in their metabolism and 
maintenance.  
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Telomeres and the end protection problem 
 
Concerning the ends protection problem, unprotected linear 
chromosomes ends can activate two main DNA damage sensing 
and signaling pathways: one dependent on ATM (Atassia 
Telangiectasia Mutated) activation, usually induced by the 
presence of ds-breaks, and the other triggered by ATR (Atassia 
Telangiectasia and Rad3 related) recruitment, predominantly 
activated by the presence of single-strand (ss)-breaks (Harper, 
2007). Briefly ATM is normally activated following its recruitment 
at damaged DNA by MRN (Mre11-Rad50-Nbs1) complex that 
associates with the ds-break, and its auto-phosphorylation, while 
ATR activation requires the binding of RPA (Replication Protein 
A) to ssDNA following by ATRIP (ATR interacting protein) 
recruitment that in turn brings ATR at damaged site. Once 
activated ATM and ATR activate a phosphorylation-mediated 
signaling cascade that involves the phosphorylation and the 
consequent activation of different factors, such as Chk1 and Chk2, 
and, as finale effect, triggers cell cycle arrest and DNA repair 
pathway activation (Harper, 2007). Potentially telomeres have the 
features to activate both these pathway because they are ends and 
they showed a constitutive region of ssDNA, so mechanisms have 
to be evolved to avoid their activation at natural ends. Moreover 
two DNA repair pathway can be activated in mammalian cells to 
repair ds-breaks and are reported to be activated at unprotected 
chromosomes ends: Non Homologous Ends Joining (NHEJ) and 
Homologous Recombination (HR). NHEJ is an error prone repair 
pathway that joins together ds-breaks in a sequence-independent 
way; NHEJ is activated essentially when the heterodimer Ku70/80 
binds a free end and a key factor of this pathway is DNA ligase IV 
that promotes the ligation of the ends (Lieber, 2010). When NHEJ 
is activated at unprotected telomeres it can lead to formation of 
end-to-end fusions that can block the cell cycle progression or, if 
checkpoint mechanisms are bypassed and the cells with fused 
chromosomes enter in mitosis, they can create problems during 
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chromosomes segregation and can become the starting point of a 
breakage-fusion-bridge cycle, source of genomic instability 
(O’Sullivan, 2010; Palm, 2008). HR, in principle, is an error free 
repair mechanism mainly when it’s activated following S-phase 
and sister chromatids can be exploited as template. It requires 
Rad51 to promote strand invasion and following processing of 
derived structures that can involve different nucleases (Heyer, 
2010). Unprotected telomeres could be subjected to different types 
of inappropriate HR that could have all detrimental effects because 
they could cause unequal exchanges between two chromosomal 
ends or they could bring to loss of chromosomal regions and to 
chromosomal rearrangements that can threaten genome stability 
(Palm, 2008). In recent years it has become clear that telomere 
dysfunction could have a major role in the establishment of 
genome instability that could lead to cancer development, 
underlying the importance of a complete understanding of telomere 
metabolism and biology (O’Sullivan, 2010). 
 
How telomeres solve the end protection problem: t-loop and 
higher order structure 
 
Telomeres solve the ends protection problem following two 
different but interlinked strategies: the formation of higher-order 
DNA structures that sequester the linear ends, and the constitutive 
binding of a specialized protein complex, the shelterin, that either 
has an active role in avoiding the recognition of chromosomes ends 
as ds-breaks and facilitates the formation and/or stabilizes these 
protective secondary structures (de Lange, 2010; Paeschke, 2010; 
Chan, 2010). A well documented example of telomeric higher 
order structure with protective function is the t-loop (Figure 1), a 
large duplex lariat structure identified first in human and mouse 
cells by electron microscopy (Griffith, 1999) and later observed in 
a large variety of different organisms such as trypanosomes 
(Munoz-Jordan, 2001), ciliates (Murti, 1999), plants (Cesare, 
2003) and C. elegans (Raices, 2008). T-loops are likely formed by 
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3’-overhang looping back and by its strand invasion of duplex 
telomeric repeats, displacing the G-strand at the base of the loop, 
forming a so-called displacement loop (D-loop) (Palm, 2008; de 
Lange, 2004). The size of the loop is highly variable and it seems 
to not influence its function; it ranges from 0.3 Kb in trypanosomes 
(Munoz-Jordan, 2001) to 30 Kb in mice and 50 Kb in peas (Cesare, 
2003); moreover it varies also between telomeres of a single cell 
(Palm, 2008). It has been proposed that T-loop formation, hiding 
telomere ends, could prevent the access of DNA–binding ends 
factors involved in DNA repair, such as MRN complex or 
Ku70/80, inhibiting in this way, respectively, the activation of 
ATM-mediated DNA response and of NHEJ pathway (de Lange, 
2009). It has been suggested that shelterin components and in 
particular TRF2, described in detail below, could have a role in 
promoting t-loop formation and stabilization due to its ability to 
facilitate t-loop formation (Griffith 1999; Stansel, 2001) and to 
promote strand invasion in vitro (Amiard, 2007). However it has 
not yet been determined if TRF2 is necessary for t-loops 
maintenance in vivo. Moreover some other aspects of t-loop 
biology has not yet been fully elucidated, for example is not clear 
if t-loops are present at each telomere in vivo, or if their formation 
is cell cycle regulated and if and how they are resolved to allow 
telomeres replication (Paeschke, 2010; Palm, 2008). An alternative 
higher order structure proposed for telomeres is the G-quadruplex; 
its formation involves the association of four different guanines 
into a cyclic Hoogsteen hydrogen bonding arrangement (Maizels, 
2006). G-overhang can form intra- or inter- molecular G-
quadruplex structures in vitro but their in vivo occurrence has been 
demonstrated only in ciliates (Paeschke, 2008; Paeschke, 2010), so 
further investigations are needed to clarify if these structures are 
present at telomeres of higher eukaryotes cells in vivo, to 
understand how their formation could be regulated and how they 
can contribute to telomere maintenance (Paeschke, 2010). 
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Figure 1: Model of mammalian telomeres structure. 
G-overhang folds back and invades upstream dsDNA, forming the t-loop. Shelterin 
components and nucleosomes, in brown, are represented. Adapted from Pisano, 2008. 
 
 
 
How telomeres solve the end protection problem: shelterin 
 
The second solution to the end protection problems in mammalian 
cells is represented by the above mentioned six-subunits protein 
complex, that is part of telomeres, called shelterin (Figure 1). 
Shelterin enables cell to distinguish their natural chromosomes 
ends from ds-breaks, represses DNA repair reactions and regulates 
telomerase mediated telomere-lengthening, as described in the next 
sections (Palm, 2008). The components of shelterin complex 
specifically localize to telomeres; they are abundant at telomeres 
throughout the cell cycle; they work exclusively at telomeres and 
don’t have function elsewhere in the nucleus (Palm, 2008). The 
specificity of shelterin for telomeric DNA is due to the recognition 
of TTAGGG repeats by two of its components: TRF1 and TRF2 
(Telomeric Repeat binding Factor 1 and 2) that bind the ds part of 
telomeres with their Myb/SANT-type DNA binding domain 
(Broccoli, 1997; Palm, 2008; de Lange 2010). The complex 
contains also a third DNA binding protein, POT1 (Protection Of 
Telomeres 1) that binds ss TTAGGG repeats with its two OB 
(oligosaccharide/oligonucleotide binding) fold domains; POT1 
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binding activity is crucial for telomeres protection but doesn’t have 
a role in anchoring the shelterin complex at telomeres (Loayza, 
2003; de Lange 2010). POT1 is recruited at telomeres through its 
interaction with another component of shelterin complex, TPP1 
(known also as TINT1, PTOP, PIP1) (Liu, 2004; Ye, Hockemeyer, 
2004; de Lange, 2010). TPP1 binds to TIN2 (TRF2- and TRF1-
Interacting Nuclear protein 2), the linchpin of shelterin complex, 
that interacts also with TRF1 and TRF2, providing a bridge 
between the shelterin components that bind to ds and ss telomeric 
DNA and connects also TRF1 and TRF2 (Ye, Donigian, 2004; 
O’Connor, 2006; de Lange 2005; Palm 2008). The last shelterin 
component is Rap1, the human ortholog of the yeast 
Repressor/Activator Protein 1, that is recruited at telomeres 
through its interaction with TRF2 (Li, 2000; Chan 2010). 
Shelterins form a stable complex also in the absence of telomeric 
DNA (Palm, 2008) and the TRF1/TRF2/TIN2/Rap1 core of 
shelterin is very abundant; a recent study suggests that human 
telomeres could contain hundred of copies of this complex 
potentially covering all telomeric DNA (Takai, 2010). The same 
study estimates also that POT1/TPP1 complexes are less abundant, 
about 50 copies per telomere, but it indicates that POT1 is likely to 
be present in excess of its ss binding site (Takai, 2010; de Lange, 
2010). The shelterin complex is highly conserved in mammals, 
including mice that are frequently used for gene targeting studies. 
The only distinctions in rodents is the presence of two POT1 
genes, Pot1 a and b, both interacting with Tpp1 and approximately 
equal abundant at telomeres, but with different functions 
(Hockemeyer, 2006). Shelterin proteins are essential to survival of 
mammalian cells, as their depletion either drives cells into cellular 
senescence or results in early embryonic lethality (Chan, 2010).  
Each protein of the complex plays a specific role in chromosomes 
ends protection and in telomeres homeostasis and, for this reason, 
we are going to analyze them more in detail. TRF1 and TRF2 share 
a common domain structure consisting of the TR homology 
domain (TRFH) and a C-terminal SANT/Myb DNA-binding 
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domain, which are connected through a flexible hinge domain 
(Broccoli, 1997). The N terminal part of the two proteins is 
different and confers them the possibility to interact with different 
telomeric accessory proteins and to recruit specific subset of 
accessory factors to telomeres: the N terminus of TRF2 contains a 
Gly/Arg rich domain, named GAR domain or basic domain, 
whereas TRF1 has acidic aminoacids at its N terminus (Broccoli, 
1997; Palm 2008). Both TRF1 and TRF2 recognize telomeric 
DNA by their SANT/Myb domain and bind TTAGGG repeats as 
homodimers or oligomers formed through homotypic interaction in 
the TRFH domain; they don’t interact directly (Broccoli, 1997; 
Fairall, 2001; Court, 2005). Both TRF1 and TRF2 are subjected to 
regulative modifications, such as parsylation, ubiquitylation, 
sumoylation or phosphorylation, but the functional consequences 
of these modifications are not yet been fully understood (Palm, 
2008). TRF2 plays a main role in chromosomes ends protection 
selectively blocking the activation of ATM (Denchi, 2007) and 
NHEJ pathways at telomeres (van Steensel, 1998; Smogorzewska, 
Karlseder, 2002; Celli 2005). Indeed when TRF2 is deleted in 
mouse embryonic fibroblasts (MEFs) or inhibited with a dominant 
negative allele in human cells, most, if not all, telomeres become 
sites of a DNA damage activation signal that is mediated by ATM. 
Cytologically, this event is readily detectable as the formation of 
DNA damage foci located at telomeres named TIFs (telomere 
dysfunction-induced foci) containing DNA damage response 
factors, as γH2AX, 53BP1, MDC1 and activated ATM (Takai, 
2003; Celli, 2005; Dimitrova, 2006). Following TRF2 depletion 
TIFs form in all stages of interphase cells (Konishi, 2008). This 
DNA damage response activation appears to be ATM dependent 
and when ATM or components of MRN complex are genetically 
inactivated in MEFs the deletion of TRF2 fails to induce TIFs 
formation (Celli, 2005; Denchi, 2007; Attwool, 2009; Deng, 2009; 
Dimitrova, 2009). Consistent with the activation of ATM pathway, 
TRF2 deletion triggers phosphorylation of Chk2 and the activation 
of p53/p21 pathway leading to cell cycle, prevalently G1/S, arrest. 
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In fibroblast this arrest is accompanied by senescence while in 
other cell types it can induce apoptosis (van Steensel, 1998; 
Karlseder, 1999; Smogorzewska 2002). Currently two models are 
proposed to explain how TRF2 can block ATM activation at 
telomeres: in the first model TRF2 can directly repress ATM 
activation given that it can interact with ATM and its 
overexpression can inhibit ATM activation also at nontelomeric 
sites (Karlseder, 2004); the second model invokes a key role for 
TRF2 in maintaining a higher-order structure at telomeres in which 
the DNA free ends sensed by ATM are hidden, as in t-loop 
structure, because, as mentioned before, TRF2 seems able to 
promote t-loop formation in vitro (Griffith 1999; Stansel, 2001). 
According to this second model, t-loop impedes MRN loading on 
DNA end by simple occlusion, preventing ATM activation (de 
Lange, 2010). TRF2 has also a crucial role in blocking NHEJ 
activation at telomeres. Indeed TRF2 inhibition, in p53 KO MEFs, 
generates numerous chromosome end fusions, resulting in long 
strings of joined chromosomes (van Steensel, 1998; 
Smogorzewska, 2002; Celli, 2005). NHEJ takes place primarily in 
G1 phase, but also postreplicative fusions are observed in TRF2 
KO cells (Konishi, 2008). The depletion of other shelterin 
components don’t lead to this massive telomeric fusions phenotype 
suggesting that TRF2 is the principle responsible for NHEJ 
inhibition at telomeres. However TRF2-mediated repression of 
telomere fusions is sufficient to protect chromosome ends in G1, 
but after DNA replication additional mechanisms are required and 
these involve POT1 and also nonshelterin proteins, like Apollo (de 
Lange, 2009). The molecular mechanism by which shelterin 
prevents NHEJ activation at telomeres is still unclear. The current 
model is similar to the t-loop model for ATM repression; again 
TRF2 could act in favouring the formation or stabilization of the t-
loops that are expected to block Ku70/80 loading on chromosomes 
ends thereby preventing NHEJ activation at its first step (de Lange, 
2010). TRF2 is important also in repression of HR at telomeres, 
although the heterodimer Ku70/80, an accessory factors recruited 
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at telomeres through its interaction with shelterin components, has 
a key role in telomere protection from this kind of DNA repair and 
in particular in inhibiting telomere sister chromatid exchanges 
(TSCEs) (Celli, 2006). However the highest incidence of TSCEs is 
observed when both TRF2 and Ku70 are depleted (Celli, 2006). 
TRF1 has a minor role in telomere ends protection; it stabilizes and 
enforces POT1 binding to telomeres and, as discuss below, it’s 
principally involved in regulating telomerase dependent telomeres 
elongation and in semi-conservative telomeric repeats replication. 
In this last context the absence of TRF1 can activate an ATR 
mediated DNA damage response at telomeres during S-phase 
progression (Sfeir, 2009). Nevertheless this DNA damage 
activation is due to a replication problem that arises at telomeric 
repeats when TRF1 is deleted and can lead to fragile-site-like 
phenotype at telomeres (Sfeir, 2009), that is analyzed more in 
detail in the next section.  
Rap1 is a constitutive binding partner of TRF2 and it’s dependent 
on TRF2 for its telomeric localization and stability (Li, 2000; Li, 
2003). It is dispensable for telomere protection from ATM and 
NHEJ activation at telomeres because deletion of Rap1 in TRF2 
proficient cells doesn’t lead to telomere fusions or TIFs formation 
(Martinez, 2010; Sfeir, 2010). Rap1 seems to have an important 
role in repressing HR; indeed in Ku70 KO context, Rap1 depletion 
induces high frequency of TSCEs (10% of chromosome ends) 
(Martinez, 2010; Sfeir, 2010). How Rap1 protects telomeres from 
HR is not clear; it’s likely that Rap1 has an interacting partner that 
block HR (de Lange, 2010). Moreover Rap1 has a role in telomere 
length regulation. 
A crucial role in telomere capping is played by POT1. This 
shelterin protein in its N terminus has two OB-fold domains with 
which it can recognize G-overhang (Lei, 2004; Loayza, 2004). 
POT1 contains also a third OB-fold domain at its C terminus 
(Theobald, 2004). POT1 has a preference for TAGGGTTAG site at 
3’ end and its binding is stimulated by TPP1; however it can bind 
at many positions along G-overhang, suggesting that POT1/TPP1 
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can bind ss telomeric repeats in a 3’ end independent way, 
indicating that POT1 can bind also D-loops when telomeres are in 
t-loops configuration (Palm, 2008). POT1 has a crucial role in 
repressing ATR pathway activation at telomeres. Simultaneous 
depletion of Pot1 a and b from MEFs results in TIFs formation at 
most telomeres and elicits a cell cycle arrest; this DNA damage 
response is unaltered in ATM-deficient cells but it’s diminished 
when ATR is inhibited (Hockmeyer, 2006; Denchi, 2007). POT1 
depleted cells show phosphorylation of both Chk1 and Chk2 and 
this modification is reduced in the absence of functional ATR 
(Denchi, 2007). In mouse cells, Pot1a is the primary factor in 
repressing ATR signaling whereas Pot1b has a subsidiary role in 
this context (Hockmeyer, 2006); however Pot1b is important for 
G-overhang length regulation (Hockmeyer, 2008). Since ATR 
signaling is activated following RPA binding to ssDNA, a simple 
competition model has been proposed to explain how POT1 
represses ATR pathway at telomeres. According to this model 
POT1 and RPA compete for the binding to ssDNA at telomeres 
ends and the presence of POT1 at ss telomeric repeats would block 
RPA binding thereby preventing ATR activation (de Lange, 2009). 
Consistent with this model, normally RPA is not observed at 
telomeres but when both Pot1 a and b are depleted, RPA is 
detectable at telomeres; moreover RPA is required for ATR 
pathway activation at unprotected telomeres (Gong, 2010). 
However RPA is a very abundant protein, in contrast POT1 is 
much less abundant; moreover the affinity of POT1 for ss 
telomeric DNA is in the same range of RPA binding affinity, even 
when POT1 is bound to TPP1 (de Lange, 2010). Despite these 
considerations POT1 is able to exclude RPA from ss telomeric 
DNA; likely POT1 wins the competition with RPA for ss 
TTAGGG repeats because it’s tethered to telomeres by the other 
shelterin components. Indeed through its TPP1-TIN2 link, POT1 
accumulates at telomeres and this connection provides POT1 with 
two telomeric binding sites, one through POT1-ss telomeric DNA 
interaction and the other through protein-protein interaction that 
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connects POT1 to TRF1 and TRF2 and so to ds TTAGGG repeats 
(de Lange, 2009; de Lange, 2010). POT1 is also important for 
NHEJ repression after DNA replication. Its involvement in 
inhibition of this pathway is demonstrated by the mild telomeres 
fusion phenotype that is observed in human cells following POT1 
reduction and in mouse cells depleted of both Pot1 a and b 
(Veldman, 2004; Hockemeyer, 2005). Interestingly these fusions 
involve sister chromatids indicating a postreplicative event 
(Hockemeyer, 2006). The current model proposes that POT1 
loading on the ss overhang keeps the repair pathway inactive until 
higher-order telomeric structure is reformed after semiconservative 
replication; this last process involves also nonshelterin telomeric 
proteins, as Apollo (de Lange, 2010). Moreover POT1 is required 
for the repression of HR at telomeres. Indeed, as happens for Rap1, 
the depletion of both Pot1 a and b in the context of Ku70 null mice, 
induces high incidence of TSCEs (Palm, 2009). For HR repression 
it could be important the ability of POT1 to compete with ssDNA 
binding proteins, because HR beginning involves the binding of 
both RPA and Rad51 to ssDNA (de Lange, 2009).  
TIN2 has a crucial role in stabilizing shelterin complex and so both 
in ends protection and in telomeres length regulation. Indeed TIN2 
is able to interact simultaneously with TRF1, using its C terminus, 
and with TRF2, using its N terminus (Ye, Donigian, 2004); in this 
way TIN2 forms a bridge between TRF1 and TRF2 stabilizing and 
enforcing the binding of the two proteins at telomeres. Consistent 
with this, TIN2 reduction in human cells has a profoundly 
destabilizing effect on shelterin, inducing a reduction of TRF2 
telomere-bound levels. Moreover TIN2 recruits TPP1, and 
therefore POT1, to telomeres, using a third protein interaction site 
distinct from its TRF2 binding site but located at its N terminus. 
This kind of interaction has a crucial importance for POT1 
recruitment at telomeres and for POT1 dependent telomere ends 
protection from ATR pathway (O’Connor, 2006).  
As TIN2 also TPP1 takes part in ends protection promoting POT1 
recruitment at telomeres. Indeed TPP1 can bind both POT1 
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through a centrally located interacting domain, and TIN2 through 
its C-terminal domain (Liu, 2004; Ye, Hockemeyer, 2004). At its 
N terminus is present an OB-fold domain that can interact with 
telomerase suggesting that this shelterin component can be 
involved also in telomeres length regulation (Xin, 2007). TPP1 is 
essential to recruit and stabilize POT1 at telomere ends 
(Hockemeyer, 2007) and its depletion or the expression of a mutant 
form of TPP1 unable to bind POT1, leads to removal of all POT1 
from telomeres generating a telomere deprotection phenotype 
consistent with POT1 loss (Hockemeyer, 2007; Liu, 2004; Kibe, 
2010). Moreover TPP1 is essential also for POT1 nuclear 
localization: POT1 mutants lacking TPP1 interacting site, are 
excluded from the nucleus and also TPP1 downregulation 
diminishes the amount of nuclear POT1 (Chen, 2007).  
 
How telomeres solve the end protection problem: nonshelterin 
telomeric proteins 
 
In addition to shelterin complex, mammalian telomeres contain a 
large number of nonshelterin telomeric proteins, also called 
accessory proteins, that give an important and essential 
contribution to chromosomes ends maintenance and protection. 
The nonshelterin proteins are typically less abundant at telomeres 
than shelterin and some of them are only transiently associated to 
telomeres; moreover, unlike shelterin components, these proteins 
have also nontelomeric function. Most of them  are involved in 
DNA transactions, such as DNA repair, DNA damage signaling, 
chromatin structure and often are recruited to telomeres by 
interaction with shelterin components, in particular TRF2 and 
TRF1 (Palm, 2008). Since nonshelterin proteins normally function 
in DNA processing, at one hand they facilitate shelterin tasks and 
take part in chromosomes ends protection, but on the other hand, 
these factors are potentially harmful for telomeres. This paradox 
suggests that shelterin must carefully control and regulate 
nonshelterin proteins actions, although mechanisms used for this 
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control have not yet be fully elucidated (de Lange, 2005). There 
are a lot of nonshelterin factors associated to telomeres and acting 
in their metabolism; for most of them telomeric function has been 
elucidated but for some of them it is still enigmatic. Among the 
best characterized nonshelterin telomeric proteins, particularly 
interesting are DNA-PKcs and the above mentioned heterodimers 
Ku70/80. These proteins normally promote NHEJ but they 
associate to telomeres through interaction with shelterin; ironically 
they are involved in NHEJ and HR repression at telomeres. Indeed 
mouse cells depleted of DNA-PKcs show a significant increase in 
end-to-end fusions (Bailey, 1999; Goytisolo, 2001; Bailey, 2001) 
indicating that its function is important for chromosomes ends 
protection. Moreover all the three subunits of DNA-PK have found 
to be associated to telomeres (d’Adda di Fagagna, 2001). Ku70/80 
is a very important factor in telomeres protection from HR and it 
has been observed at telomeric repeats (Hsu, 1999). Depletion of 
TRF2 or POT1 or Rap1 alone is not sufficient to induce TSCEs; 
when Ku70/80 is present, even when NHEJ is blocked, exchanges 
are rare (Celli, 2006). How Ku70/80 acts to prevent TSCEs has not 
been established but it may be related to its general ability to 
repress homologous recombination, or it could be important the 
association with shelterin to repress HR at telomeres (de Lange, 
2010). Another DNA damage repair protein that acts paradoxically 
at telomeres is ERCC1/XPF; this nuclease is implicated in the 
processing of G-overhang after telomere damage but it’s essential 
to prevent the recombination of telomeric ends with TTTAGG-like 
interstitial sites (Zhu, 2003). This phenomenon can potentially lead 
to terminal deletions in which chromosomes lose all sequences 
distal the interstitial TTTAGG repeat array and produce an 
extrachromosomal elements, double minute chromosomes (TDMs) 
that contain the deleted segment with most of the original 
telomeres (Palm, 2008). These TDMs are observed in cells lacking 
ERCC1 (Zhu, 2003) and it has been proposed that ERCC1/XPF 
endonuclease could promote the cleavage of the strand-invaded 
intermediate (Palm, 2008). Another nonshelterin protein that can 
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counteract TDMs formation is the RecQ helicase WRN that acts 
particularly when telomeres are short (Laud, 2005). WRN is 
important also to repress TSCEs formation; indeed, when it’s 
absent, in a telomerase negative setting, frequent TSCEs are 
observed (Laud, 2005). It has been proposed that WRN can block 
recombination at telomeres moving the Holliday junction, deriving 
by strand-invasion, toward end terminus (Palm, 2008). The 
engagement of WRN at telomeres is paradoxically because it has 
been demonstrated that in vitro WRN can resolve the t-loop 
structures and degrade G-overhang (Opresko, 2002; Opresko, 
2004). However WRN is recruited at telomeres by TRF2 in S-
phase (Crabbe, 2004; Machwe, 2004) and it’s important also for 
telomeres replication because in the absence of WRN, S-phase 
dependent telomere loss has been observed (Bai, 2003; Crabbe, 
2004). It has been proposed that WRN could be important to 
unwind G-quadruplex structures from telomeric repeats that could 
impede telomere replication (de Lange, 2005; Paeschke, 2010). 
Apollo nuclease is another nonshelterin protein that has been 
implicated telomeres replication and in the generation of G-
overhang after replication. Indeed the reduction of Apollo in 
human cells induces TIFs and DNA damage response activation in 
S-phase cells, suggesting its involvement in telomere replication 
(Lenain, 2006; van Overbeek, 2006). Apollo depletion generates 
fusions that involve the leading ends (Lam, 2010; Wu, 2010) and 
for this reason it has been proposed that TRF2 recruits Apollo at 
the leading ends of telomeres to regenerate G-overhang at this 
strand that presumably is blunt right after replication (de Lange, 
2010). It’s possible that the regeneration of G-overhang after 
replication requires also the recruitment at telomeres, maybe 
operated by TRF2, of other nonshelterin factors as MRN complex 
or ATM (de Lange, 2010).  
Other nonshelterin telomeric identified proteins are: Bloom 
helicase (BLM), PARP1 and 2, tankyrases, Rad51, 9-1-1 complex, 
ORC, HP1 proteins, PINX1, PIN1, FEN1, SLX4, Mus81, BRCA1 
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but it’s likely that this list will grow (de Lange, 2005; Palm, 2008; 
de Lange, 2010; Chan, 2010; Giannone, 2010).  
Recently three additional nonshelterin telomeric factors are 
identified in mammalian cells and, in particular, in human cells, 
that are the homologues of yeast CST complex components 
(Miyake, 2009; Surovtseva, 2009). Budding yeast telomeres are 
not protected by a shelterin-like complex; although the ds 
telomeric repeats are bound by Rap1 and two associated factors; 
these proteins are not involved in chromosomes ends protection. 
Instead this function is fulfilled by a trimeric complex, CST, 
comprised of Cdc13, Stn1, Ten1, which bind G-overhang. In yeast 
CST plays a dual role in telomeres protection and modulation of 
their replication (Price, 2010). This complex is related to RPA 
complex but performs a different biological function (Gao, 2007; 
Sun, 2009). The mammalian CST complex is formed by Ctc1-
Stn1-Ten1 (Miyake, 2009), localizes at telomeres but several lines 
of evidences suggest that it can have both telomeric and 
nontelomeric functions: it binds ssDNA in a sequence independent 
manner and shows also nontelomeric localization (Price, 2010). 
Depletion of CST components in human cells leads to an increase 
in G-overhang length and induces telomere dysfunctions and 
genome instability (Miyake, 2009; Surovtseva, 2009). It has been 
proposed that CST complex in mammalian cells has a minor role in 
chromosomes ends protection but it could play a role in G-
overhang generation and maintenance (Dai, 2010). Basing on the 
analysis of the nature of telomere dysfunctions generated by its 
loss, it could be important for telomeres replication but it can also 
take part in replicative processes in presence of replication stress. 
In this context, specifically, this complex may serve as a DNA 
polα/primase recruitment factor at telomeres or where replication 
stress induces the accumulation of ssDNA and the need to re-
initiate leading or lagging strand synthesis (Price, 2010; Sampathi, 
2011). 
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How telomeres are replicated and the end replication problem 
 
Telomere maintenance is based on conventional semiconservative 
replication, which accounts for the bulk of telomeric DNA 
synthesis, and additional mechanisms could be present to extend 
G-strand, which as discussed below, shortens each replication 
round. The replication of eukaryotic genomes initiates 
bidirectionally at defined origins. At chromosomes ends, the last 
origin is expected to be responsible for the replication of telomeric 
sequences (Gilson, 2007). Currently, except in few organisms, 
there has been little evidence of initiation of DNA replication 
within the telomeric repeats themselves (Makovets, 2004), so 
telomeric replication is thought to start from an origin located in 
subtelomeric region (Liew, 2009; Sampathi, 2011). Replication 
forks move bidirectionally from subtelomeric origins towards 
telomeric repeats; replication terminates when the fork reaches the 
chromosome end. Given the conserved directionality of the 
telomeric repeats, the new G-strand is always synthesized by 
leading-strand synthesis, and the new C-strand by lagging-strand 
synthesis; it means that parental G-strand is replicated by 
discontinuous lagging synthesis generating new C-strand and vice 
versa parental C-strand is replicated by leading synthesis 
generating new G-strand (Liew, 2009). Due to the inability of 
DNA polymerase to replicate in 3’-5’ direction and the consequent 
necessity of primers to start the replication of parental G-strand, 
the removal of the last 5’ primer from the newly synthesized C-
strand leaves it incomplete. In this way the newly replicated C-
strand would progressively shorten, eventually compromising 
telomere function and resulting in loss of genetic information. This 
has become known as the end replication problem. Most organisms 
solve this matter by the action of telomerase, a reverse 
transcriptase that is able to add new telomeric repeats at 
chromosomes ends and that is active in specific tissues and cell 
types. Moreover different mechanisms involving retrotransposition 
or recombination can compensate this erosion (Gilson, 2007), as 
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discussed more in detail in the next section. The lagging end 
resulting from removal of the last primer is thought to have already 
a G-overhang, whereas the leading end resulting from replication is 
thought to be blunt ended. 5’ resection is necessary for 3’-overhang 
generation and Apollo, a nonshelterin telomeric protein, has been 
implicated in this process (Wu, 2010). Apollo probably is not the 
only nuclease that mediates the generation of 3’-overhang at 
leading strand because when Apollo is absent leading telomere 
fusions occur but are not frequent (Lam, 2010; Wu, 2010), 
suggesting that there is another pathway that can generate 3’-
overhang when Apollo is missing. One possibility is that the ATM 
signaling at telomeres lacking Apollo is responsible for 5’ 
resection. MRN mediated ATM activation can induce the resection 
at telomeres, as happens at ds-breaks, most likely through CtIP 
nuclease (de Lange, 2010). Indications of ATM and MRN 
involvement in G-overhang generation come from experiments in 
which TRF2 is deleted in cells lacking MRN or ATM (Attwool, 
2009; Dimitrova, 2009).  
Telomeres appear to be one of the most difficult-to-replicate 
genomic regions: during the passage through telomeric repeats, 
replication fork faces a number of potential challenges due to their 
long G-rich repetitive nature and their unique chromatin structure 
(Sampathi, 2011). Moreover, due their terminal position, stalled 
fork in the telomere cannot be rescued by a converging fork, and is 
likely to result in incomplete telomeric DNA replication (Liew, 
2009). Replication fork stalling at telomeres can activate a 
ATM/ATR mediated DNA damage response leading to cell growth 
arrest or creating a situation that may lead to accelerated telomere 
attrition (Sampathi, 2011). For these reasons telomeres resemble 
fragile sites resulting from defects in replication and are prone to 
deletions and chromosome rearrangements (Sfeir, 2009). 
Telomeric proteins facilitate replication fork passage through 
telomeric repeats ensuring their complete replication. One of the 
challenges that replication fork need to solve during telomeric 
DNA replication is the presence of secondary structures such as G-
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quadruplex or t-loop, described above. The formation of these 
structures may contribute to telomere function, but these structures 
have to be tightly regulated as they could impede replication fork 
passage and telomerase mediated elongation (Paeschke, 2010). 
Their resolution requires the actions of RecQ helicases BLM and 
WRN; these proteins can unwind G-quadruplex structures 
(Mohaghegh, 2001) and they could also resolve telomeric D-loop 
to allow passage of replication fork and/or telomerase access 
(Crabbe, 2004). WRN and BLM activity at telomeres is regulated 
and stimulated by shelterin proteins, in particular TRF2 and POT1 
(Opresko, 2002; Lillard-Wetherell, 2004; Opresko, 2004). 
Moreover WRN deficient cells specifically lose telomeres 
replicated by lagging-strand synthesis (Arnoult, 2009) and, 
confirming its importance for telomere replication, WRN localizes 
at telomeres during S-phase (Crabbe, 2004).  
Recently it has been emerged a predominant role for TRF1 in 
efficient telomere replication. Loss of TRF1 leads to aberrant 
telomere structural changes resembling common fragile sites, 
which activate ATR pathway during S-phase; moreover single 
molecule analysis of replicated DNA reveals that the absence of 
TRF1 weakens replication efficiency, suggesting that TRF1 
promotes efficient replication of telomeric DNA by preventing 
fork stalling (Sfeir, 2009; Martinez, 2009). It’s not completely 
clear how TRF1 promotes efficient telomeric replication, but it has 
been proposed that it acts recruiting additional factors as BLM or 
RTEL1 to stalled replication fork at telomeres promoting its 
stabilization and re-starting (Sfeir, 2009; Paeschke, 2010).  
Mammalian telomeres, although heterochromatic and difficult to 
replicate, differently from yeast telomeres that are replicated in 
concert late in S-phase (Friedman, 1995), replicate throughout all 
S-phase (Wright, 1999).  
In mammalian somatic cells, that lack telomere length maintenance 
pathway, each round of DNA replication is accompanied by a net 
loss of 100-200 bp, as consequence of incomplete replication of the 
ends and of the post-replicative processes that are involved in 
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restoration of overhang and protective structure formation. 
Telomere shortening at each cell division is more than that 
predicted from primer removal and it’s likely that postreplicative 
phenomenon of C-strand resection, described above, happens at 
both replicated ends (Huffman, 2000). As a function of the rate of 
replication associated shortening and initial telomere length, a 
somatic cell can only undergo a defined number of doublings 
before telomeres become critically short, lose their protective 
properties and send cells into a terminal arrest termed replicative 
senescence, or cause cell death (O’Sullivan, 2010). This 
mechanism limits the replicative lifespan of individual cell and 
probably of some cellular compartments in organisms and 
therefore is a tumour suppressive pathway that prevents cells from 
becoming immortal. The fact that most cancer need to activate a 
telomere length maintenance pathway for survival, emphasizes the 
protective role of telomere attrition (O’Sullivan, 2010). The bulk of 
telomeres in human primary fibroblasts that enter in senescence 
seems to be around 4kb (Karlseder, 2002) and only one telomere 
that reaches a critically short length is enough to induce cell cycle 
arrest (Hemann, 2001). Critically short telomeres activate a DNA 
damage response that is similar to that triggered by the presence of 
uncapped telomeres and ultimately induce cell cycle arrest or 
apoptosis (d’Adda di Fagagna, 2003). However germ line cells, 
and highly proliferative tissues require the activation of telomere 
length maintenance pathway to counteract the loss of terminal 
DNA at each cell division. 
 
How telomeres solve the end replication problem: telomerase 
 
Most eukaryotes counteract telomere attrition thanks to telomerase 
(Greider, 1985; Greider, 1987). This is a ribonucleoprotein enzyme 
with two components: a highly conserved reverse transcriptase 
(TERT) (Nakamura, 1997; Lingner, 1997) and an associated 
template RNA (TERC) (Feng, 1995). TERT is related to the 
reverse transcriptase of non-LTR retroposons and group II introns 
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and like these, it extends the 3’ end of a DNA, rather than RNA, 
primer (Nakamura, 1998; Smogorzewska, 2004). The RNA 
component of telomerase diverged quickly in evolution, but 
TERCs from different organisms share common structural features, 
including a pseudoknot and an open loop containing the template 
for telomeric repeats synthesis (Romero, 1991; Chen, 2000). The 
template region in mammalian TERCs (AAUCCCAAUC) serves 
for both the annealing with 3’-overhang and the addition of one 
telomeric repeat per elongation step (Palm, 2008). The primer for 
telomerase is the chromosome terminus, which can be positioned 
on an alignment site in TERC such that the 3’ end of the telomere 
is adjacent to the template sequence. Extension of the telomere 
terminus results in the addition of one telomeric repeat, and 
repeated alignment and extension steps can endow chromosome 
ends with the direct repeat arrays typical of telomeres. After 
elongation of 3’ end, C-strand synthesis is presumably required to 
create ds telomeric DNA (Smogorzewska, 2004). Telomerase 
activity is strongly suppressed in human somatic cells; its activity 
is restricted to ovaries, testes and highly proliferative tissues 
(Cong, 2002). This regulation takes place primarily regulating 
transcription levels of hTERT gene, whereas hTERC is virtually 
ubiquitous. For this reason, forced expression of hTERT in human 
primary fibroblasts is sufficient to reconstitute telomerase activity 
and counteract telomere erosion, immortalizing the cells (Ramirez, 
2001). Tumour cells require a telomere maintenance system for 
long-term proliferation, and in the majority of cases, 85%, this is 
provided upregulating hTERT (Henson, 2002). However 
telomerase activity per se doesn’t induce transformation (Morales, 
1999; Smogorzewska, 2004), and, although telomerase is 
necessary for immortalization, hTERT is not an oncogene (Hahn, 
1999; Hahn, 2002; Smogorzewska, 2004); moreover, cancer cells 
can activate also alternative mechanisms to counteract telomeres 
attrition.  
Despite variation in the length of individual telomeres within a cell 
or an organism, the average telomere length of telomerase-positive 
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cells is kept in a narrow species-specific range, indicating a 
balance between telomere erosion and telomere elongation. This 
equilibrium is due to regulation of telomerase in cis by telomeric 
protein (Palm, 2008). The key regulatory principle in telomere 
length homeostasis is the presence of a negative feedback in which 
the product of telomerase, the telomeric DNA, binds to an inhibitor 
of telomerase in an amount proportional to telomere length (van 
Steensel, 1997; Marcand, 1997). In mammalian cells shelterin 
complex represents telomerase inhibitor that regulate its activity; 
indeed the level of shelterin bound to telomeres increases with the 
number of TTAGGG repeats and is used to “count” telomere 
length (Palm, 2008). TRF1 has a key role in this process; indeed 
TRF1 binds to ds telomeric repeats and the total number of TRF1 
molecules per chromosome end is correlated with the length of 
telomeric tract (van Steensel, 1997). Moreover, TRF1 is a negative 
regulator of telomerase since its overexpression causes telomeres 
shortening, whereas its partial inhibition, through expression of a 
dominant negative allele, causes telomeres elongation (van 
Steensel, 1997). Experiments performed using a mutant TRF1 
tethered to a subtelomeric site, showed that TRF1 can limit 
telomerase dependent elongation in cis (Ancelin, 2002). Moreover, 
negative regulators of TRF1 that inhibit its binding to telomeres, as 
tankyrase 1 and 2, are positive regulators of telomerase activity; 
indeed their overexpression removes TRF1 from telomeres leading 
to telomere elongation (van Steensel, 1997) enforcing the idea that 
TRF1 is a key regulator of telomere lengthening. Also other 
shelterin components as TIN2, TPP1 and POT1 behave as negative 
regulators of telomerase (Palm, 2008). TIN2 appears to stabilize 
TRF1 at telomeres and protects TRF1 from being modified by 
tankyrase inhibiting TRF1 dislodgement activity (Kim, 1999). 
POT1 has a crucial function in the direct inhibition of telomerase. 
Diminished POT1 loading at 3’-overhang or its replacement with a 
mutant lacking of ssDNA binding domain causes a telomerase 
dependent telomeres elongation (Loayza, 2003; Ye, Hockemeyer, 
2004). Moreover POT1 and telomerase compete in vitro for ss 
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overhang binding (Lei, 2005) suggesting that POT1 could act as a 
terminal transducer that relays the information about telomere 
length from TRF1 to chromosomes ends (Palm, 2008). Consistent 
with this model is the finding that TPP1 depletion causes telomeres 
elongation; its removal reduces POT1 recruitment at telomeres 
leaving chromosomes ends accessible to telomerase (Liu, 2004). 
Data on TRF2 and Rap1 are also consistent with a role as negative 
regulators of telomeres length but their contribution is less defined 
(Li, 2003; O’Connor, 2004; Smogorzewska, 2000; Palm, 2008). 
This regulation system, in which shelterin proteins are used to 
“count” telomere length and to regulate telomerase activity, 
ensures that in a cell, telomerase acts preferentially at short 
telomeres that present low levels of bound shelterin, elongating 
them and is less active at long telomeres that presents a higher 
quantity of bound shelterin avoiding to add further repeats. As a 
consequence, telomeres, in a given telomerase positive cell, tend to 
converge to a similar median telomere length setting 
(Smogorzewska, 2004). 
 
 
How telomeres solve the end replication problem: alternative 
lengthening mechanisms 
 
Mammalian cells have the ability to activate telomerase-
independent telomere maintenance pathways, collectively termed 
ALT (Alternative Lengthening of Telomeres) (Bryan, 1997; 
Reddel, 2003; Neumann 2005). All cancer telomerase negative 
cells, around 15%, maintain their telomeres through ALT 
mechanisms (Reddel, 2001). ALT cells, differently from 
telomerase positive cells, are characterized by heterogeneous 
length phenotype with an average length higher than telomerase 
positive cells, for human cells is around 20 kb, and a wider 
distribution of telomeres length of the same cells, in human cells 
ranging from 3 kb to 50 kb. Telomere length distribution in ALT 
cells is dynamic, with fluctuation in length occurring on individual 
Romina Burla 
Pag 38  
telomere during cellular proliferation and with rapid and drastic 
changes in individual telomere length (Henson, 2002). Moreover 
ALT cells show frequent sequence exchanges between sister 
telomeres (Londono-Vallejo, 2004). ALT mechanism of telomere 
maintenance is based on intertelomeric HR; different models can 
explain ALT mechanism: a ssDNA at the end of one telomere can 
invade dsDNA of another telomere and can use it as a copy 
template, or telomere lengthening can be achieved by a 
recombination mediated rolling circle of replication that can also 
use t-loops as templates (Henson, 2002). ALT cells are also 
distinguished by the presence of nuclear structures referred to as 
ALT-associated PML bodies or APBs (Yeager, 1999) that are 
different from the other PML bodies for their content: it includes 
telomeric DNA and shelterin TRF1 and TRF2 and a lot of proteins 
involved in DNA replication and recombination as Rad51, Rad52, 
RPA, Mre11, Rad50, Nbs1, BLM and WRN. They could 
represents sites specialized for ALT telomere elongation (Henson, 
2002).  
Another alternative mechanism of telomere elongation based on 
retrotransposition is present in Drosophila and some related 
Dipteran species (Biessmann, 1990), as discussed more in detail 
below. 
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Drosophila Telomeres 
 
Drosophila telomeres are remarkable because they are maintained 
by telomere-specific retrotransposons, rather than by the 
telomerase that maintains telomeres in the other eukaryotic 
organisms. While Drosophila telomeres appear to be physically 
very different from those of other species, the differences are not 
so strong as they can appear and moreover the function of 
telomeres is totally conserved in Drosophila despite the different 
mechanisms used to reach it (Mason, 2008). 
In Drosophila, telomeres, as those of the other eukaryotes, are 
composed of tandem repeats, but while in most eukaryotes they are 
simple and short (6-8 bp), in fly repeats are longer (6-12 kb) and 
more complex. Differently from the other organisms in which 
telomeres are devoid of genes, in Drosophila, telomeric repeats 
codify for the proteins involved in retrotrasposons mobilization. 
Indeed in this organism terminal repeats consist of arrays of 
telomere-specific non-long terminal repeats (LTR) 
retrotransposons, HeT-A, TART and TAHRE (collectively HTT 
elements) (Figure 2), present on multiple copies on normal 
telomeres and able to “heal” broken chromosome ends (Mason, 
1995; Pardue, 1997; Abad, 2004; Pardue, 2005; Mason, 2008). All 
three elements have very long 3’ untranslated regions (UTR); 
TART and TAHRE each have two open reading frames (ORFs) 
whereas Het-A has only one ORF (Frydrychova, 2008). ORF1, 
which is found in all three elements, encodes a GAG-like protein 
that binds to RNA retroelement and transports it back to the 
nucleus (Rashkova, 2002). ORF2 encodes a reverse transcriptase 
(RT) and it lacks in Het-A, so it’s likely that the RT required for 
Het-A transposition derives from TAHRE and acts in trans also on 
Het-A (Figure 2) (Abad, 2004; Shpiz, 2007).  
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Figure 2: Telomeric non-LTR retrotrasposons.  
GAG and RT ORFs are indicated. 3’UTR are long at least 3 kb and 3’oligo(A) tail used 
to attach at chromosomes ends are indicated by AAAAAA. Adapted from Frydrychova, 
2008.  
 
 
 
 
 
In Drosophila these three elements are involved in telomere 
elongation that, as in all other organisms, is necessary to counteract 
telomere shortening due to ends incomplete replication. Telomere 
elongation by addition of HTT elements to the chromosome end 
can occur by two distinct mechanisms, terminal conversion or 
targeted transposition (Frydrychova, 2008). HTT elements 
specifically transpose at chromosome ends and likely this 
specificity is due to Het-A GAG activity that can associate to 
chromosome ends (Figure 3) (Rashkova, 2003). Although the 
details of this process remain unresolved, in the proposed 
mechanism, RT of HTT elements could use free 3’ terminus at 
chromosome end to prime reverse transcription and new HTT 
elements are added specifically at chromosome end in an head-to-
tail arrangement with their oligo(A) tails always facing towards the 
centromere (figure 3) (Mason, 2008).  
Gene conversion is a recombination based mechanism in which 
HTTs at the end of a chromosome are used as template for the 
elongation of another chromosome following a strand invasion 
step, that either involved sequences on the homologous 
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chromosome or tandemly arranged sequences on the same 
chromosome (Mikhailovsky, 1999; Kahn, 2000). Both in 
Drosophila and in the other eukaryotes that present telomerase 
based telomere elongation, telomeres are a product of a reverse 
transcription reaction and, as in the other species, although 
alternative recombination based elongation mechanisms are 
present, RNA-templated extension predominates also in 
Drosophila  (Pardue, 2005; Frydrychova, 2008).  
 
 
 
 
 
 
Figure 3: Model for extension of chromosomes end by telomeric retrotransposons.  
Arrows represent head to tail array of Het-A (blue) and TART (green) that form the 
telomere. Transcription of an element of the array provides sense RNA (purple) that is 
translated in cytoplasm to yield GAG protein (yellow). This protein associates with RNA 
and delivers it to chromosome end where the RNA is reverse transcribed onto the 
chromosome. Adapted from Pardue, 2011. 
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As in the other eukaryotes, telomere lengthening is under the 
control of telomere associated proteins. Among them HP1 encoded 
by Su(var)205, as described more in detail later, is the only 
identified protein that takes part both in telomere length regulation 
and in telomere capping. Mutations in Su(var)205 cause telomere 
elongation enhancing both the transcription of HeT-A and TART 
and the frequency of their transposition at chromosome ends. 
Moreover also gene conversion is increased in Su(var)205 mutants 
and involves tandem telomeric arrays of the same chromosome 
(Savitsky, 2002). These findings indicate that HP1 is a negative 
regulator of Drosophila telomeres length.  
Heterodimer ku70/80 is an important negative regulator of 
telomere lengthening in Drosophila, but differently to its role in 
mammalian cells, it doesn’t take part in telomere protection (Cenci, 
2005). Mutations in ku70 and ku80 encoding genes increase the 
terminal transposition of HeT-A and TART without affecting their 
expression and enhance also terminal gene conversion both with 
tandem sequences of the same chromosome and of the homologous 
chromosome (Melnikova, 2005). 
Drosophila telomere elongation is also promoted by mutation in 
Tel and E(tc) genes; Mutations in Tel induce a substantial increase 
in HeT-A and TART addition at chromosome ends (Siriaco, 2002) 
whereas mutations in E(tc) trigger terminal elongation by gene 
conversion using tandem arrays of the same chromosome as 
template (Melnikova, 2002). 
Despite the obvious differences, HTTs sequence exhibits a strand 
bias in nucleotide content that resembles that seen in telomerase-
generated telomeres sequences in other organisms (Mason, 2008) 
and they could form G-quadruplex structures (Abad, 1999; Mason, 
2008). Moreover also in Drosophila, moving from chromosome 
end toward the centromere, telomere associated sequences (TAS) 
are present adjacent to HTT arrays. TAS region consists of several 
kilobases of complex satellite sequences, which varies among 
telomeres, although there are sequence similarities (Mason, 2008). 
It seems evident that HTT has a unique pattern of histones 
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modifications, including both heterochromatic and euchromatic 
marks as K3Me3K9, K3Me3K27 and H4AcK12 respectively. 
Nevertheless in Drosophila, as in the other organisms, telomeres 
are considered heterochromatic for two reasons: they contain 
repetitive DNA and they are able to repress the expression of genes 
inserted into telomeric regions. This telomere position effect (TPE) 
has been described first in Drosophila and later in the other 
eukaryotes; in fly the source of this effect was localized to TAS 
(Biessmann, 2005; Mason, 2008). 
Not all telomeres in Drosophila include HTT array and moreover, 
several indications suggest that a telomeric protective cap can be 
formed in a sequence independent way (Cenci, 2005). Indeed, 
although the concept of telomere was conceived by Muller to 
account for the failure to recover terminally deleted chromosomes 
after X irradiation (Muller, 1938), subsequent experiments have 
demonstrated that these terminal deficiencies can be recovered in 
the presence of mu2 mutation in females (Mason, 1984). These 
terminal deficiencies can be transmitted over many generations in a 
wild type background (Mason, 1995) and their molecular analyses 
have shown that they don’t terminate with HTTs and continuously 
recede losing 75 bp per fly generation; for this reason, they never 
terminate with the same DNA sequence suggesting a sequence-
independent mechanism for Drosophila telomere capping 
(Biessmann, 1990; Cenci, 2005). Moreover terminal deficiency 
chromosomes lacking HTT array have been found in natural 
populations (Mechler, 1985) and also in laboratory stocks (Mason, 
2004). In addition, telomere capping proteins are normally 
recruited at the ends of terminally deleted chromosomes (Fanti, 
1998; Cenci, 2003; Cenci 2005) enforcing the idea that Drosophila 
telomeres are capped in a sequence independent way and that 
virtually any DNA sequence has the ability to form the 
nucleoprotein complex that protects the ends of chromosomes, a 
feature that is proper of this organism. 
Telomere protection and maintenance also in Drosophila requires 
the end specific binding and the action of different proteins. The 
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identification of these proteins has mainly relied on the isolation of 
mutants that show frequent telomere fusions in larval brain cells; 
molecular analysis of the genes specified by these mutants has 
allow the identification of loci required to prevent end-to-end 
fusions (Cenci, 2005). Among the identified proteins four of them 
seem to localize and work exclusively at telomeres; they form a 
complex called terminin that has all the features of shelterin and 
has been proposed to be its functional analog (Raffa, 2011). 
Terminin components are: HOAP (HP1/ORC-associated protein) 
(Cenci, 1997, Cenci, 2003), Moi (Raffa, 2009) and Ver (Raffa, 
2010); mutations in their encoding genes, Caravaggio (cav), 
Modigliani (moi) and Verrocchio (ver) respectively, cause very 
high frequency of telomeric fusions and produce multicentric 
linear chromosomes that resemble little “trains” of chromosomes. 
Moreover they interact directly with each others and they localize 
exclusively at the ends of polytene chromosomes (Raffa, 2011). 
HOAP localizes to telomeres also on mitotic chromosomes (Cenci, 
2003; Cenci 2005), whereas Moi and Ver were not detected at 
mitotic chromosomes ends, probably due to their low abundance 
(Raffa, 2009; Raffa, 2010). An additional terminin protein is 
HipHop (HP1-HOAP interacting protein), which has been 
identified among the proteins that co-precipitate with HOAP (Gao, 
2010). HipHop directly interacts with HOAP, specifically localizes 
at both mitotic and polytene chromosomes ends and seems to work 
only at telomeres (Gao, 2010). Very little is known about the 
structural features of the complex: it’s clear that HipHop and 
HOAP are mutually dependent for their stability and that Moi and 
Ver are mutually dependent for their localization at telomeres that 
requires also HOAP (Raffa, 2011). Moreover HOAP binds ds 
DNA of different sequences, although with different affinities and 
Ver contains an OB-fold domain that is similar to that of 
Rpa2/STN1 and binds ssDNA of different sequences (Raffa, 2010; 
Raffa 2011). HOAP and HipHop localize to the ends of terminally 
deleted chromosomes suggesting that these proteins bind 
chromosome ends independently of terminal DNA sequences 
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(Raffa, 2011). Currently it’s unknown if Moi and HipHop directly 
bind DNA. Moreover mutations in cav, moi or ver not cause 
telomere elongation indicating that terminin, differently from 
shelterin, is not implicated in telomere length control (Raffa, 2011) 
enforching the idea that telomere elongation and telomere 
protection are partially separate processes in Drosophila (Cenci, 
2005).  
In addition to end-to-end fusions, the presence of uncapped 
telomeres triggers also a DNA damage response in Drosophila 
cells as happens in the other eukaryotes. Among the terminin, 
HOAP seems to play a key role in preventing not only telomere 
fusions but also DNA damage checkpoint activation (Ciapponi, 
2008). Indeed mutations in cav gene lead to extensive end-to-end 
fusions and affect cell cycle progression. This response is 
dependent on ATR pathway activation, because mutations in the 
genes encoding for proteins involved in this pathway can alleviate 
the cell cycle block (Cenci, 2005; Musarò, 2008). The activation of 
this DNA damage response seems independent from ATM 
pathway and it has not yet been elucidated if the cell cycle arrest 
happens at G1/S phase transition or in G2/M transition (Ciapponi, 
2008). Moreover HOAP-depleted telomeres also cause cell cycle 
arrest during the metaphase-to-anaphase transition due to spindle 
assembly checkpoint (SAC) activation that is likely mediated by 
BubR1 recruitment at telomeres that require both ATM and ATR 
pathway (Musarò, 2008). These findings indicate that in 
Drosophila, similar to mammals and yeast, dysfunctional 
telomeres, HOAP-depleted, trigger DNA damage response 
activation that lead to interphase cell cycle arrest. Moreover, in 
Drosophila unprotected telomeres recruit BubR1 that activates 
SAC, blocking mitotic division of cells with dysfunctional 
telomeres escaped the DNA damage checkpoint and preventing in 
this way genomic instability (Ciapponi, 2008). Depletion of Moi or 
Ver don’t activate a DNA damage response or SAC (Cenci, 2009) 
suggesting that these terminin proteins are essential to hide 
chromosome ends from the DNA damage machineries that mediate 
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telomere fusions but are not required to prevent checkpoint 
activation (Raffa, 2011). It has not yet been fully elucidated if 
HipHop is necessary to protect telomeres from DNA damage 
response. 
In addition to telomeric specific proteins, Drosophila telomeres 
require also accessory proteins for their proper protection; these 
nonterminin proteins, although necessary for telomeric capping 
have also other localizations and other functions in the cell, as 
nonshelterin telomeric proteins in mammalian cells. Genetic and 
molecular studies have identified seven of these proteins required 
for telomere protection from fusion events: HP1, UbcD1, Mre11, 
Rad50, Nbs, ATM and WOC (Raffa, 2011). Among them one of 
the most important for telomere capping is HP1 (Fanti, 1998). This 
protein is involved in different cellular processes as gene silencing, 
chromosome structure and transcriptional regulation in addition to 
telomere protection (Fanti, 2008; Vermaak, 2009). HP1 localizes to 
the ends of polytene chromosomes in addition to chromocenter and 
many euchromatic bands (Fanti, 1998; Fanti, 2003). Mutations in 
its encoding gene cause high level of telomere fusions (Fanti, 
1998). Moreover HP1 is the only telomeric protein for which has 
been described a function both in ends protection and in telomere 
length regulation (Frydrychova, 2008). HP1 interacts with HOAP 
(Badugu 2003, Cenci, 2003), Moi but not with Ver (Raffa, 2009; 
Raffa, 2010) and localizes to the extremities of terminally deleted 
chromosomes, as terminin proteins. However HP1 should not be 
considered a terminin component, because it doesn’t localize 
exclusively at telomeres and has multiple telomere-unrelated 
functions (Raffa, 2011). HP1 doesn’t seem necessary for HOAP 
localization at telomeres because in Su(var)205 mutant strains, 
mitotic telomeres accumulate regular amount of HOAP (Cenci, 
2003). 
UbcD1 is the first gene shown to be required to prevent telomeric 
fusions in Drosophila (Cenci, 1997). It encodes for an highly 
conserved E2 ubiquitin conjugating enzyme that has role in 
different cellular processes (Cenci, 1997); it remains to be 
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determined which are its telomeric targets and which function, 
regulative or degradative, could have the modification mediated by 
UbcD1. In Ubcd1 mutants HOAP and HP1 are correctly localized 
at telomeres, suggesting that UbcD1 is not necessary for their 
recruitment to chromosome ends (Cenci, 2003). 
Woc is another telomeric nonterminin factor; it encodes for a zinc-
finger protein that is located at the ends of polytene chromosomes 
and co-localizes with euchromatic bands that associate with 
initiating form of polymerase II (Raffa, 2005). Woc localizes at 
telomeres independently of the other telomeric proteins and is not 
required for terminin localization at telomeres (Raffa, 2011). 
In Drosophila, as in mammalian cells several proteins involved in 
DNA damage sensing and repair are involved in ends protection. 
Mutants in Mre11, Rad50 and Nbs1 exhibit telomere fusions and 
chromosome breaks in larval brain cells (Bi, 2004; Ciapponi, 2004; 
Ciapponi, 2006; Oikemus, 2006), although their incidence is lower 
than that of terminin mutants. Moreover Mre11, Rad50 and Nbs1 
depletions reduce HOAP accumulation at mitotic telomeres and 
both HOAP and HP1 localization at the ends of polytene 
chromosomes (Bi, 2004; Ciapponi, 2004; Ciapponi, 2006; 
Oikemus, 2006); Mre11 mutants show also a reduction of Moi 
localization at polytene telomeres (Raffa, 2009). These findings 
suggest that MRN complex components are necessary to recruit 
terminin at chromosome ends likely because interaction of ends 
with MRN complex results in conformational changes that 
facilitate terminin recruitment at telomeres (Cenci, 2005). 
However, even in the absence of MRN activity, mitotic 
chromosomes retain the ability to recruit low levels of HOAP that 
are likely enough to partially protect chromosome ends, as 
suggested by the finding that MRN components mutants display 
fewer fusions than terminin mutants (Cenci, 2005; Rong, 2008, 
Raffa, 2011). As in mammalian cells, also ATM kinase is 
important for telomere protection in Drosophila. Mutations in its 
encoding gene result both in telomere fusions and chromosome 
breaks in larval neural cells (Queiroz-Machado, 2001; Bi, 2004; 
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Oikemus, 2004; Silva, 2004) and don’t affect HOAP localization at 
mitotic telomeres although they reduce HOAP accumulation at the 
ends of polytene chromosomes (Bi, 2004; Oikemus, 2004). It’s not 
clear how ATM prevents telomere fusions but it seems to act in a 
different way in comparison to MRN components (Cenci, 2005, 
Raffa 2011). Mutations in ATR and ATRIP encoding genes don't 
cause telomere fusions but increase the incidence of them in 
tefu/atm mutants, suggesting that ATM and ATR/ATRIP play 
partially redundant roles at telomeres (Bi, 2005; Raffa, 2011). 
In conclusion, while at a first glance telomeres in Drosophila 
appear totally different in comparison of those of the other 
eukaryotes, they share several features and are functionally 
equivalent. It has been hypothesized that Drosophila has a 
telomerase positive ancestor and during the transition from a 
telomerase-based to transposon-based telomere elongation 
mechanism, Drosophila, rapidly evolved specialized proteins, 
teminin, to bind chromosome ends independently of DNA 
sequence. According to this hypothesis, terminin proteins are not 
conserved in the other eukaryotes and shelterin proteins are not 
conserved in flies, while telomeric associated nonterminin and 
nonshelterin proteins are largely conserved from flies to mammals, 
and many of them play telomere-related functions in both 
organisms. These findings indicate that the main difference 
between Drosophila and human telomeres is in the telomeric 
sequence and in the protective cap that specifically binds these 
different structures (Raffa, 2011). For these reasons and 
considering the main conservation in humans of nonterminin 
proteins, cytological screenings of mutant strains that allow the 
identification of new proteins of this type in Drosophila, may lead 
to the discovery of new human telomeric proteins. 
Recently it was identified a new telomeric gene pendolino (peo) by 
a cytological screening of larval neural cells of tardive lethal 
mutant strains (Cenci, manuscript in preparation). Mutations in peo 
gene cause high incidence of telomeric fusions with a mean of 4 
fusions per metaphase. These fusions in anaphase generate 
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chromosomal bridges that often are resolved without break 
inducing polyploidy and/or aneuploidy. Moreover, peo telomeric 
function was confirmed by cytological screening of strains 
obtained crossing peo heterozygous mutants with Su(var)205 or 
cav or UbcD1 heterozygous mutants: mutations in peo increase the 
frequency of telomeric fusions in these double mutants 
demonstrating that these genes genetically interact. GST-pull down 
experiments and two hybrid assays shown that PEO protein 
interacts physically with HOAP but not with HP1 (Cenci, 
manuscript in preparation). Peo encodes for a protein that shares 
similarities with E2 ubiquitin conjugating enzyme but it lacks of a 
cysteine important for catalytic reaction so it is not clear which is 
its molecular role. Peo is conserved in mammals and its human 
homologue AKTIP is the subject of this study. 
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AKTIP and Ft1: state of art 
 
 AKTIP gene is located on long arm of chromosome 16 (16q12.2), 
and encodes for a 33 KDa protein. Very little is known about this 
human protein: it was identified as an interactor of Ser/Thr kinase 
B (PKB)/AKT1 by a cDNA screening using a GFP-AKT as bait 
(Remy, 2004) and it takes its name from this identified interaction. 
In this overexpression-based study, AKTIP seems to act as a 
protein bridge between AKT1 and its upstream kinase PDK1 
increasing the efficiency with which it regulates AKT1 activation 
and contributing in this way to modulate its activity (Remy, 2004). 
However in a subsequent study AKTIP was found to interact with 
all three human Hook proteins (1-2-3) but the authors failed to 
identify AKT1 among AKTIP interactors. They suggest that this 
difference is due to different experimental conditions used and that 
the interaction previously found, could be ascribed to 
overexpression conditions (Xu, 2008). In this study AKTIP is 
proposed as a member of a complex that could be involved in 
vescicle trafficking and/or fusion via the HOPS complex (Xu, 
2008). 
Recently AKTIP/FTS was identified as a factor involved in 
cervical carcinogenesis; it is overexpressed in the progressive 
grade of cervical cancer and negatively regulates tumour 
suppressor p21 (Cinghu, 2011). It was identified as a putative 
target to improve radiation therapy of cervical cancer cells. Indeed, 
silencing of AKTIP/FTS in HeLa cells was found to promote cell 
cycle arrest and apoptosis following radiation; however it’s not 
clear the molecular mechanism underlying this process 
(Anandharaj, 2011). 
Preliminary bioinformatic and biochemical studies conducted in 
our laboratory have allowed the identification of AKTIP as a 
member of Ubiquitin E2 variant (UEV) family. These proteins are 
characterized by the presence of a domain that has obvious 
similarity with UBC domain (Figure 4) but lacks the catalytic 
cysteine that is crucial for ubiquitin transfer reaction and they have 
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different roles in ubiquitin conjugation from that performed by 
canonical E2s (Broomfield, 1998; Sancho 1998). UEV proteins 
play a central role in the assembly of K63-linked polyubiquitin 
chains (Hofmann, 1999; Ulrich, 2000), a regulative modification 
involved in different signaling pathways (Hofmann, 2009). The 
best characterized UEV proteins in mammals are MMS2 
(Hofmann, 1999) and UEV1a (Andersen, 2005); they work 
together with a canonical E2, Ubc13 in the assembly of K63-chains 
and are involved in DNA damage response. A well known target of 
the regulative ubiquitilation operated by these two UEVs is PCNA, 
a replicative factor that has a key role in replication fork 
progression and regulation (Moldovan, 2007). This particular 
modification is important to trigger the DNA damage tolerance that 
allows resumption of DNA synthesis in presence of lesions that 
block the replication forks progression and that induce prolonged 
fork stalling potentially leading to fork collapse (Chen, 2011).  
 
 
 
 
 
 
 
Figure 4: Schematic 3D structure of ubiquitin-conjugating enzyme E2 family.  
Alpha helices are represented in red and beta strands by yellow arrows. Important 
residues and motifs are represented. Adapted from Michelle, 2009. 
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Murine homologue of AKTIP is Ft1. Ft1 gene is located on 
chromosome 8, D region and it was identify in 1997 as one of 6 
genes deleted in a mouse strain obtained by insertional 
mutagenesis, Fused Toes (Ft) (Lesche, 1997). Ft/Ft homozygous 
embryos die at 9-10 day of embryonic development and display 
several abnormalities in the head development characterized by the 
absence of telencephalon and mesencephalon; moreover, they 
show a phenotype described as situs inversum viscerum 
characterized by the absence of right-left symmetry. Ft/+ 
heterozygous animals are characterized by thymic hyperplasia and 
fusions of fore limb digits (Figure 5). 
 
 
 
 
 
Figure 5: Phenotypic aberrations of Ft mutant strain.  
(A): Ft/Ft (left) 9.5- day old embryo is represented in comparison with stage matched 
wild type embryo (right). (B): skeletal stain of a wild type right fore limb (left) is 
compared to right fore limbs of Ft/+ mice (right). (C): Thymus from 6 weeks old wild 
type mouse (top on the left) is compared with ones of an age matched Ft/+ mouse (top on 
the right); a thymus from a 4 and 6 months old Ft/+ mice are presented (bottom from left 
to right). Adapted from van der Hoeven, 1994. 
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 These phenotypic features are linked to alteration of programmed 
cell death during morphogenesis (van der Hoeven, 1994). This 
aberrant phenotype is caused by a deletion of 1.6 Mb including 6 
genes: Ft1, Fatso (Fto), Ftm, Iroquois (Irx) 3, 5 and 6 (Peters, 
2002). It’s not clear which is the specific contribution of each of 
these genes simultaneously deleted in Ft mutants to the 
determination of the aberrant observed phenotype. However Irx 
genes deletion could have a main role in the mutant phenotype 
because they show a spatio-temporal regulated expression pattern 
in developing limbs, in craniofacial areas, in the developing central 
nervous system and in the heart and several of these tissues are 
affected in mutant strain (Peters, 2002). Ft1 was the first gene to be 
identified as deleted in Ft mutation because it is the most proximal 
to the integration site. Its expression is completely absent in Ft/Ft 
embryos and is reduced in Ft/+ mice. Ft1 gene contains two 
different transcription’s starting sites and two polyadenylation sites 
leading to the formation of different transcripts that differ in 5’ and 
3’ UTR and then encode for a single protein of 32 KDa. In adult 
mice, Ft1 is present in all organs analyzed. However, the 
expression level and the ratio of the Ft1 transcripts seem different 
between organs. Highest expression is present in kidney, testis, and 
brain, and lowest in spleen and liver, otherwise its expression is 
uniform in embryos starting from the day 9 of development 
(Lesche, 1997). It has not been defined which is Ft1 molecular 
function and which is its contribute to Ft phenotype. 
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AIM OF THE PROJECT 
 
Due to the paucity of information available about AKTIP/Ft1 
function in mammalian cellular metabolism we were interested in 
clarifying which is the molecular role of this protein in human 
cells. In particular the aim of this study was to understand if 
AKTIP/Ft1 has a role in human telomere metabolism and it’s 
important for telomere maintenance in mammalian cells, in 
analogy of the telomeric role of its homologue peo in Drosophila.  
This research could improve our knowledge about telomeres 
function and physiology, an expanding field that has a crucial 
importance due to the implication of telomeres in high relevant 
processes such as replicative ageing and genomic instability that is 
linked to cancer development; despite the growing number of 
information about telomere biology some questions, such as some 
aspects of telomere replication, remain open.  
This work could also be crucially important to the field of 
evolutionary biology of telomeres and it can open unattempted 
ways to look for new human telomeric proteins studying the 
mammalian homologues of Drosophila telomeric genes, despite 
the difference in their telomeres structure. 
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RESULTS 
 
AKTIP downregulation triggers cell cycle block and premature 
senescence 
 
To analyze the molecular function of AKTIP in mammalian cells 
we have chosen a reverse genetic approach studying the aberrant 
phenotype deriving by AKTIP or Ft1 lentivectors-mediated RNA 
interference, in human and murine cellular cultures. We have 
tested different short hairpin (sh) interfering sequences, five for 
AKTIP and three for Ft1 and transduction of human primary 
fibroblasts (HPF) and p53-/- murine embryonic fibroblasts (MEF) 
with the corresponding recombinant vectors (LV-shAKTIP or LV-
shFt1) has resulted in a specific and significant target mRNA 
reduction (60%-90% for AKTIP and 80%-95% for Ft1) (figure 6 
A-B). We have then tested LV-shAKTIP 09, 11, 13 efficiency also 
at AKTIP protein level in the three cellular systems that we have 
used for the subsequent experiments, HPFs, 293T and HeLa cell 
lines (figure 6 C, where LV-shAKTIP 11 is shown) and we 
obtained a significant and reproducible reduction of target protein. 
Therefore we have used these lentivectors for all the experiments 
described below. For Ft1, among lentivectors tested, we have 
chosen LV-shFt1 70 that ensured the best combination of target 
mRNA reduction and low cellular toxicity and we have used it for 
all the experiments described below. As controls we used 
untransduced mock cells or cells transduced with a vector encoding 
a scrambled sequence (LV-ctr).  
Romina Burla 
Pag 56  
 
 
Figure 6: Efficient AKTIP/Ft1 downregulation by RNA interference. 
(A-B): cDNAs obtained retrotranscribing total RNA extracted one week post infection 
(p.i.) from HPFs (A) or p53 -/- MEFs (B) transduced with the indicated recombinant 
lentivectors, were analyzed by Real Time-PCR performed using AKTIP (A) or Ft1 (B) 
specific primers. In both cases LV-ctr transduced cells were used as control. The samples 
were analyzed in duplicate and the mean value is reported; SD is shown. (C): Western 
blot showing reduced expression of AKTIP in HPFs, HeLa and 293T cells whole protein 
extracts collected 10 days post LV-shAKTIP 11 transduction compared to untransduced 
cells (mock). Probing with an anti-βactin antibody was used to normalize samples. 
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The first phenotypic trait that we have analyzed was the effect of 
AKTIP downregulation on cell cycle progression because it’s 
known that dysfunctional telomeres, due to replicative attrition of 
telomeric repeats or shelterin loss, activate a DNA damage 
response resulting in cell cycle arrest and either apoptosis or 
cellular senescence (van Steensel, 1998; D’Adda di Fagagna, 2003; 
Karlseder, 1999; Smogorzewska, de Lange, 2002). Cytological 
analysis of HPFs showed that AKTIP downregulation induced a 
strong reduction (75%- 88%) of mitotic index compared to control 
cells (figure 7 A). Western Blot analysis of protein extracts from 
AKTIP knocked down (KD) HPFs displayed a high increase in 
cyclin A level, 12-18 fold those of control cells, and a more modest 
increase in cyclin B and cyclin E levels (figure 7 B) suggesting the 
induction of cell cycle slow down or arrest following AKTIP 
downregulation. Moreover, staining for senescence associated β-
galactosidase (SA-β-GAL), an empirical marker of cellular 
senescence (Dimri, 1995), showed that, starting from eleven days 
post transduction, the frequency of SA-β-GAL positive cells was 
significantly higher following AKTIP downregulation in HPFs 
compared to control cells (figure 7 C-D). AKTIP KD HPFs 
displayed also morphological signs of senescence including large 
and flat shape. Collectively, these results indicate that AKTIP 
downregulation significantly affects cell cycle progression and 
cellular proliferation. 
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Figure 7: AKTIP downregulation triggers cell cycle arrest and premature 
senescence. 
(A): mitotic index analysis of LV-shAKTIP (09, 10 and 13) and LV-ctr transduced HPFs 
10 days p.i. Samples were analyzed in duplicate and mean value is reported; SD is 
shown. (B): Western Blot analysis of protein extracts from LV-shAKTIP 11 or LV-ctr 
transduced HPFs 10 days p.i. Probing with an anti-βactin antibody was used to normalize 
samples. Normalized band intensity quantification analysis is shown. (C-D): untreated 
(mock), LV-shAKTIP 11 and LV-ctr transduced HPFs, were tested for SA-β-GAL 
staining at the indicated time points and analyzed by contrast microscopy. (C): 
exemplificative images of SA-β-GAL stained LV-shAKTIP and LV-ctr transduced HPFs 
13 days p.i. are reported. (D): analysis of SA-β-GAL positive cells is presented. Samples 
were analyzed in duplicate and mean value is reported; SD is shown. 
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AKTIP downregulation triggers DNA damage response 
activation 
 
In agreement with the data presented above, in HPFs AKTIP 
downregulation impaired cellular population doublings kinetics 
compared to control cells (figure 8 A, left panel) confirming the 
detrimental effect of AKTIP reduction on cellular proliferation. 
However we couldn’t observe a similar response neither in 293T 
nor in HeLa cell lines: both these cell lines showed normal 
proliferation rates despite the reduction of AKTIP (figure 8 A, 
central and right panel). Considering that these two cell lines are 
characterized by altered p53 and pRb pathways (Louis, 1997; 
Sullivan, 2002; Scheffner, 1990; Dyson, 1989) that are wild type in 
HPFs, these results suggest that proliferation impairment caused by 
AKTIP reduction is induced by the activation of a cellular response 
that involved these two pathways. Since p53 is the main effector of 
cellular DNA damage response (Rinn, 2011) we hypothesized that 
AKTIP downregulation activated a DNA damage checkpoint in 
HPFs. Indeed Western Blot assays of protein extracts from AKTIP 
KD HPFs showed an accumulation, compared to control cells, of 
the active (phosphorylated) form of different proteins involved in 
DNA damage sensing and signaling (Harper, 2007), such as ATM 
(ATM PSer 1981), Chk1 (Chk1 PSer 345) and p53 itself (p53 
PSer15) (figure 8 B). The activation of p53 following AKTIP 
downregulation was further confirmed by the increase of p53 
protein level observed in protein extracts form AKTIP KD HPFs 
compared to control cells (figure 8 B, p53 tot) and also by the 
induction of its direct transcriptional target p21 (Rinn, 2011; 
Beckerman 2010), as shown by the accumulation of p21 mRNA in 
AKTIP downregulated HPFs assayed by Real Time PCR (figure 8 
C).  
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Figure 8: AKTIP downregulation impairs proliferation in HPFs triggering DNA 
damage response activation. 
(A): cumulative population doublings (p.d.) of HPFs, HeLa and 293T cell lines (from left 
to right) transduced with LV-shAKTIP (red) and with LV-ctr (black) are reported. Curves 
correlation index (R2) is shown. (B): protein extracts from LV-shAKTIP (09, 11, 13) and 
LV-ctr transduced HPFs, were analyzed by immunoblotting for the proteins indicated on 
the left. Probing with an anti-βactin antibody was used to normalize samples. (C): cDNAs 
obtained retrotranscribing total RNA extracted one week p.i. from LV-shAKTIP 11 or 
LV-ctr transduced HPFs were analyzed by Real Time PCR using p21 specific primers. 
Samples were analyzed in duplicate and mean value is reported. SD is shown 
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The induction of a strong DNA damage response following AKTIP 
downregulation was also confirmed by cytological assays. In 
AKTIP KD HPFs we observed the formation of discrete foci 
containing proteins involved in DNA damage signaling and repair 
such as γH2AX, the phosphorylated form of ATM (ATM P) and 
53BP1 (Harper, 2007) (figure 9 A-B). Both the percentage of cells 
containing five or more foci and the mean number of foci per cell 
were significantly higher in AKTIP KD HPFs compared to control 
cells (figure 9 C-D). The DNA damage signaling and repair 
proteins that we have analyzed γH2AX, ATM P and 53BP1 co-
localized at most of the foci induced by AKTIP downregulation, 
suggesting a coordinated response similar to that induced by a 
genotoxic agents, such as ionizing radiation (IR) that we have used 
as control (figure 9 E-F). DNA damage signaling and repair foci 
triggered by downregulation of AKTIP were very similar in the 
shape to those induced by IR (figure 9 A-B, the first two lines of 
both panels). These results indicate that AKTIP downregulation in 
HPFs is sufficient to trigger the activation of a strong DNA 
damage response without any treatment with genotoxic agents. 
This response, in turn, likely induces cell cycle progression block, 
proliferation arrest and premature senescence described above. 
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Figure 9: AKTIP downregulation induces DNA damage signaling and repair foci. 
(A-B): immunofluorescence (IF) showing the formation of nuclear γH2AX foci (A-B, 
green in merge), Ser1981 phosphorylated ATM foci (A, red in merge) and 53BP1 foci (B, 
red in merge) in untreated (mock), LV-shAKTIP 11 and LV-ctr transduced HPFs, 5 days 
p.i. Untransduced cells treated with IR 1 Gy were used as positive control for DNA 
damage foci formation. A magnification of the focus indicated by the arrow in merge 
image is reported in the upper right corner. DNA was stained with DAPI. (C-D): 
percentage of γH2AX (black bar), 53BP1 (grey bar) and Ser1981 phosphorylated ATM 
(white bar) foci positive cells (C) and mean number of foci per cell (D) are reported. 
Cells with more than 5 foci were considered positive. Values presented are the mean of 
two independent experiments; SD is shown. p values were based on Student t-test and 
statistical analyses were obtained comparing sample values with both controls values (p< 
0.05:(*), p<0.01:(**), p<0.001:(***)). (E-F): percentage of foci containing both protein 
γH2AX and 53BP1 versus foci containing only γH2AX or 53BP1 (E), and percentage of 
foci containing both protein γH2AX and Ser1981 phosphorylated ATM versus foci 
containing only γH2AX or Ser1981 phosphorylated ATM (F) are shown. 
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AKTIP downregulation induces TIFs formation and multiple 
telomeric aberrations 
 
Dysfunctional telomeres, as those caused, for example, by the loss 
of shelterin components, like TRF2, result in the formation of TIFs 
(telomere dysfunction-induced foci) that are DNA damage foci 
located at chromosome ends (Takai, 2003). TIFs formation can be 
monitored citologically and is considered a good means to quantify 
the extent of telomere dysfunction (Palm, 2008). For this reason 
we have decided to investigate if the DNA damage foci that we 
observed in HPFs following AKTIP downregulation, described 
above, were TIFs. For this purpose we immunostained the cells 
with both anti-TRF1, that can be used as a marker of telomeres in 
interphase cells (van Steensel, 1997), and anti-γH2AX antibodies 
(figure 10 A). Untransduced X-rays treated cells were used as 
control for the formation of DNA damage foci not linked to 
telomeric sites. We found that in AKTIP KD HPFs about 50% of 
γH2AX foci co-localized with TRF1, a frequency that is 
significantly higher than that observed in control irradiated cells in 
which more than 80% of γH2AX foci didn’t co-localize with TRF1 
(figure 10 B). In AKTIP KD HPFs more than 60% of cells 
displayed 5 or more TIFs per cell (figure 10 C), with an average of 
about 7 TIFs per cell. These results are comparable with those 
previously reported for shelterin KD (Takai, 2003) suggesting that 
AKTIP is important for telomere maintenance.  
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Figure 10: AKTIP/Ft1 downregulation induces TIFs and multiple telomeric 
aberrations. 
(A): IF showing the co-localization of γH2AX (green in merge) with telomeric sites 
marked by TRF1 (red in merge) in LV-shAKTIP 11 transduced HPFs, 5 days p.i. A 
magnification of  the focus indicated by the arrow in merge image is reported on the 
right. DNA was stained with DAPI. (B-C): percentage of γH2AX foci located at 
telomeres in each cell (B) and percentage of TIFs positive cells (C) is reported. Cells with 
5 or more γH2AX foci co-localizing with TRF1 were considered TIFs positive. The 
results shown are the mean of two independent experiments. SD is shown. p values were 
based on Student t-test (p<0.05: (*) and p<0.01:(**)). (D): representative images of 
telomeric FISH (in green) of metaphase spreads from LV-ctr or LV-shFt1 70 transduced 
p53-/- MEFs, one week p.i. DNA was stained with DAPI (false coloured in red). Most 
prominent telomeric aberrations are indicated: arrow: multiple telomeric signals (MTS), 
arrow heads: fragment with telomeric signals (TFrag.), *: sister telomere association 
(STA) and **: interchromosomal telomeric fusion. (E): Examples of telomeric 
aberrations observed following Ft1 KD are reported; a schematic representation with the 
classification of telomeric aberrations considered, is shown. (F): percentage of MTS per 
end and the percentage of STA, ETS and fusion per chromosome were determined in 
untreated (mock), LV-ctr or LV-shFt1 transduced p53-/- MEFs. Total number of ends and 
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chromosomes considered for each sample is reported. For TFrag. the frequency per 
metaphase was determined and value shown is the mean of two independent experiments. 
p values shown were based on χ2 test and statistical analyses were obtained comparing 
sample values with both controls values; (G): frequency of chromosome with one or more 
telomeric signal free ends (an example is reported) is presented. Values shown are the 
mean of two independent experiments; SD is shown. (H): Hinf I/RsaI digested genomic 
DNA extracted 13 days p.i. from HPFs transduced with the indicated lentivectors was 
fractionated on agarose gel and after blotting, telomeric DNA was detected with 
TTAGGG repeats probe. On the left marker fragments size (in Kb) positions are 
indicated. Genomic DNA of late passage (LP, passage 30) HPFs was used as control. 
 
 
Considering that TIFs represent the activation of a DNA damage 
response at dysfunctional telomeres and the high incidence of TIFs 
observed in HPFs following AKTIP downregulation, we decided to 
investigate the nature of the dysfunctions accounting for DNA 
damage response activation at telomeres in AKTIP KD cells. We 
have then used p53-/- MEFs that are frequently employed to study 
telomeric aberrations because the absence of p53 let to overcome 
the cell cycle block induced by the presence of dysfunctional 
telomeres allowing cells proliferation despite the presence of 
altered telomeres and the observation of telomeric aberrations in 
metaphase cells (Smogorzewska, Karlseder, 2002; Celli, 2005, de 
Lange 2010). FISH assay using a telomeric specific probe on 
metaphase spreads from LV-shFt1 70 transduced p53-/- MEFs, 
revealed the presence of different kinds of telomeric aberrations 
(figure 10 D). The most prominent aberrant telomeric phenotype 
induced by Ft1 downregulation was the presence of chromatids 
with multiple telomeric signals (MTS, figure 10 D-F); their 
incidence was significantly higher in Ft1 KD MEFs than in control 
cells (figure 10 F). This kind of telomeric aberrations which are 
known also as “telomeric doublets” or “fragile telomeres”, was 
recently linked to replication problems, although the specific 
mechanism that lead to their formation was not fully elucidated 
(Sfeir, 2009; Ye, 2010; Martinez, 2009; Martinez, 2010; Pennarun, 
2008; Pennarun, 2010). In Ft1 KD MEFs there was also a 
significant increase in the incidence of sister telomere associations 
(STAs, figure 10 D-F) that was two fold higher than in control 
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cells and occurred at the ends of  both short and long arm. Also this 
kind of telomeric aberrations was previously described to be linked 
to alteration of proper telomere replication (Sfeir, 2009; Ye, 2010; 
Martinez, 2009; Pennarun, 2008; Pennarun, 2010). Ft1 KD MEFs 
displayed also an increase, although not statistically significant, in 
the incidence of chromosomes with extra-telomeric signals (ETSs 
figure 10 E-F) and of fragments with telomeric signals (TFrag. 
figure 10 D-F). Ft1 downregulation induced also a significant 
increase in the frequency, although very low, of chromosomal 
fusions both with maintenance and loss of telomeric signal at the 
fusion point (figure 10 D-F). The incidence of fusions per 
chromosome, up to 2%, is comparable of that observed following 
Ft1 KO (Sfeir, 2010) but lower than that observed in TRF2 KO 
cells (Celli, 2005; Konishi 2008).  
The telomeric phenotype triggered by AKTIP/Ft1 downregulation 
was not linked to a massive loss of telomeric repeats as it was 
demonstrated by the absence of any significant increase in the 
frequency of chromosomes with one or more telomeric signal free 
ends in Ft1 KD MEFs compared to control cells (figure 10 G). In 
addition, Southern Blot analysis displayed that there was no 
change in the migration of telomeric restriction fragments from 
genomic DNA of AKTIP KD HPFs compared to control and that 
these fragments were higher than those obtained from late passage 
(30 passages) HPFs that had lost part of their telomeric repeats due 
to replicative erosion (figure 10 H), suggesting that there was no 
massive telomeric loss following AKTIP downregulation. 
Collectively, these data reveal that AKTIP/Ft1 is important for 
telomeres metabolism and its necessary for their proper 
maintenance considering that its downregulation causes the 
formation of multiple telomeric aberrations. Among these, the high 
incidence of MTSs and STAs suggests that AKTIP is more likely 
involved in telomere replication rather than in telomere protection.  
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AKTIP interacts with telomeric repeats but it doesn’t reside 
stably at telomeres 
 
Considering the telomeric phenotype caused by AKTIP 
downregulation, we have decided to investigate whether AKTIP 
interacts with telomeric repeats attempting to clarify which is its 
molecular function in telomeres metabolism. To address this 
problem we have used a ChIP assay: chromatin from untreated 
HPFs was immuno-precipitated using a anti-AKTIP commercial 
antibody or control IgG; hybridization with a telomeric repeat 
specific probe revealed the presence of telomeric DNA in AKTIP 
interacting chromatin (figure 11 A on the left). The interaction 
between AKTIP and TTAGGG repeats was also detected in HeLa 
cell line (figure 11 A on the right). The specificity of this 
interaction was supported by the lack of hybridization signal when 
it was performed using a nontelomeric probe such as that specific 
for Alu repeats both in HPFs and in Hela cells (Figure 11 A and 
C). A further confirmation of the specificity of the interaction 
between AKTIP and telomeric DNA came from the reduction of 
hybridization signal obtained using a telomeric specific probe on 
AKTIP immuno-precipitated chromatin derived from AKTIP KD 
HeLa cells (figure 11 B).  
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Figure 11:  AKTIP interacts with telomeric DNA but doesn’t reside stably at 
telomeres.  
(A): telomeric ChIP of untreated HPFs (on the left) and of untreated and LV-shAKTIP 11 
transduced HeLa cells (on the right) showing AKTIP interaction with telomeric DNA. 
Chromatin was immunoprecipitated with antibodies indicated on the left; dot blots were 
hybridized with TTAGGG repeats probe or with Alu repeats probe, as indicated on the 
bottom. (B-C): quantification of ChIP values for telomeric repeats (B) and for Alu repeats 
(C) after normalization to the input (indicated in A) was determined. Mean value of two 
experiments is reported; SD is shown. (C): IF of wild type (wt) HPFs, showing the 
absence of massive co-localization between AKTIP (green) and TRF1 (red). Cells were 
Triton X-100 extracted before IF. DNA was stained with DAPI (blue). (D): six optical 
sections captured at 1µm Z steps of IF cells are presented. 
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Given that AKTIP interacts with telomeric DNA we examined by 
cytological screening its possible co-localization with TRF1, again 
used as a marker of telomeres in interphase cells. Immunostaining 
with both anti-AKTIP and anti-TRF1 antibodies in HPFs revealed 
the lack of an obvious co-localization between the two proteins 
(figure 11 D). This finding became particular evident looking at 
optical sections captured at 1µm Z steps above and below the focal 
plane of immunostained cells (figure 11 E); their analysis 
underlined that AKTIP and TRF1 have different localization in the 
nucleus with AKTIP that is highly enriched at nuclear rim (for 
detailed analysis of AKTIP localization refer to the next section) 
and TRF1 that is distributed throughout the nucleoplasm.  
These data indicate that AKTIP interacts with telomeric DNA but 
it’s not a stable component of telomeres lacking of co-localization 
with TRF1. This last finding, in addition to the AKTIP emerging 
telomeric role, indicates that AKTIP has to be considered as an 
accessory telomeric protein, which are defined as proteins that, 
differently from shelterin components, don’t reside stably at 
telomeres but are important for proper telomeres maintenance 
(Palm, 2008).  
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AKTIP co-localizes with nuclear lamina and it’s important for 
genome stability 
 
To investigate further AKTIP molecular function we have 
analyzed in detail its cellular localization. 
Immunostaining with an anti-AKTIP antibody of untreated wild 
type HPFs revealed both a cytoplasm and nuclear localization 
(figure 12 A). Following extraction with a mild detergent that 
removed the soluble part of the proteins allowing the study of 
subnuclear localization (Zhu, 2000), AKTIP displayed a nuclear 
localization, with a peculiar punctate pattern with high enrichment 
at nuclear rim both in HPFs and in HeLa cells (figure 12 A). 
AKTIP immunostaining signal was strongly reduced in AKTIP KD 
HPFs (figure 12 A) confirming the specificity of the anti-AKTIP 
antibody used. Moreover a highly enriched localization at nuclear 
periphery was obtained using anti-Flag antibody on extracted 293T 
cells previously transfected with a Flag tagged version of AKTIP 
protein (figure 12 A). We have then evaluated AKTIP distribution 
in optical sections of extracted immunostained cells (figure 12 B). 
We have quantified AKTIP signal in two focal sections and in the 
two more distal sections, above and below the focal plan, 
considering, for each section, AKTIP amount in two regions of the 
nucleus, a peripheral one (edge), and a central one. Comparison of 
obtained values confirmed AKTIP enrichment at nuclear periphery 
(figure 12 C).  
This peculiar distribution recalls that of lamins, intermediate 
filaments that are the principal constituents of nuclear lamina, a 
filamentous network of proteins associated to the inner nuclear 
membrane. In mammals two types of lamins compose the nuclear 
lamina: A-type (A and C) and B-type (B1 and B2) (Dechat, 2010).   
Immunostaining of HPFs with both anti-AKTIP and anti-Lamin B1 
antibodies displayed high co-localization of the two proteins at 
nuclear periphery (figure 12 D), suggesting the possibility of an 
interaction, direct or indirect, between AKTIP and lamin proteins. 
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Figure 12: AKTIP in the nucleus localizes mainly at nuclear rim and co-localizes 
with lamin B.  
(A): IF of wt HPFs and HeLa cells showing AKTIP (green) localization. LV-shAKTIP 
transduction in HPFs resulted in a reduction of the signal (third column from the left). A 
similar localization was obtained using an anti-Flag antibody (green) on 293T cell line 
expressing AKTIP-Flag (on the right). Where indicated the cells were Triton X-100 pre-
treated. DNA was stained with DAPI (blue). (B): six optical sections captured at 1µm Z 
steps of immunostained with anti-AKTIP HPFs are shown. (C): analysis of AKTIP signal 
localization in the nucleus obtained comparing the signal distribution in the two more 
distal sections (the first and the last from the left in B) and in the two focal sections (the 
third and fourth from the left in B) in 23 immunostained cells, is reported. The percentage 
of signals located in the central part of the nucleus and the percentage of those located at 
the edge of the nucleus were calculated. The values presented are the mean of two 
experiments. SD is shown. p values were based on a Student t-test (p< 0.01:(**)). (D): IF 
of wt HPFs showing AKTIP (red in merge) and Lamin B1 (green in merge) co-
localization at nuclear rim. Two representative images are presented. DNA was stained 
with DAPI. A magnification of rim indicated in merge is presented on the right.  
Romina Burla 
Pag 72  
Given the importance of lamins for the maintenance of genome 
stability (Gonzalez-Suarez, Redwood, Perkins, 2009; Gonzalez-
Suarez, Redwood, Gonzalo, 2009) and the suggestion that AKTIP, 
as telomeric nonshelterin protein, could have also a nontelomeric 
function, we decided to assess the putative contribution of AKTIP 
in genome stability maintenance. Cytological analysis of 
metaphase spreads from Ft1 KD p53-/- MEFs showed that Ft1 
downregulation induced a 4 fold increase compared to control cells 
of chromosomal aberrations including breaks, gaps, fragments and 
complex rearrangements (figure 13 A-B). These aberrations could 
be a direct consequence of AKTIP/Ft1 downregulation and/or a 
consequence of telomeric fusions-breakage-bridge cycle 
(O’Sullivan, 2010). Nevertheless the low frequency of telomeric 
fusions observed in Ft1 KD MEFs, the absence of massive 
telomere erosion in AKTIP KD HPFs and the lack of any increase 
in telomere loss in Ft1 KD MEFs, described above, argue against a 
strong contribution of this second possibility in our context. 
Moreover we observed that AKTIP KD HPFs were more sensitive 
to low doses of aphidicolin (APC) in comparison to control cells. 
The APC doses used in our experimental conditions are enough to 
create replication stress and are commonly used to induce fragile 
sites expression (Durkin, 2007); fragile sites are genomic regions 
prone to replication fork stalling or collapse (Glover, 2005; Durkin, 
2007). Analysis of metaphase spreads from AKTIP downregulated 
HPFs treated with low doses of APC displayed a significant 1.5-2 
fold increase in chromosomal breaks or gaps compared to control 
cells (figure 13 C-D). 
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Figure 13: AKTIP is important for genomic stability maintenance. 
(A): Giemsa stained metaphase spreads from untreated, LV-ctr and LV-shFt1 transduced 
p53-/- MEFs, one week p.i., showing the presence of chromosomal aberrations following 
Ft1 downregulation indicated by the arrows and magnified on the right. (B): percentage 
of chromosomal aberrations per metaphase was considered and mean values of 
chromosomal aberrations observed in 50 metaphases are reported. p value reported was 
based on Student t-test; statistical analysis was obtained comparing sample value with 
both controls values. (C): DAPI staining of untransduced, LV-ctr and LV-shAKTIP 
transduced HPFs, following 24h incubation with aphidicolin (APC) 0.4 µM showing the 
presence of breaks/gaps indicated by arrows and magnified in the lower corner. (D): 
percentage of breaks and gaps per chromosomes is reported and the number of analyzed 
chromosomes is indicated. p value shown was based on χ2 test and statistical analysis was 
obtained comparing sample value with both controls values. 
 
 
 
Collectively, these results indicate that AKTIP in the nucleus is 
mainly located at nuclear rim where it co-localizes with Lamin B1 
enforcing again its classification as accessory telomeric protein. In 
agreement with this, the data presented above indicate that AKTIP 
plays a role in genome stability maintenance and strengthen its 
possible involvement in DNA replication not only of telomeres, as 
described above, but also of other genomic regions, like fragile 
sites, that pose a challenge for replication machinery.  
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AKTIP downregulation impairs proper DNA replication 
 
 Some phenotypic features deriving by AKTIP/Ft1 downregulation 
described so far suggest that AKTIP could contribute to DNA 
replication. We thus analyzed cell cycle distribution of AKTIP KD 
HPFs by flow citometry analysis (FACS) of BrdU/PI stained cells. 
Control asynchronous cells analysis displayed that part of the 
cellular population, around 25% of analyzed cells, was in S-phase 
of cell cycle; these cells had a DNA content, measured by PI 
incorporation, that was intermediate between those of G1 and G2 
and a significant BrdU incorporation (figure 14 A, left panel). In 
contrast ten days after transduction, FACS analysis of AKTIP KD 
HPFs revealed that a consistent proportion of cells, 45%, was 
blocked in S-phase, because they had DNA content proper of S-
phase cells but they couldn’t incorporate BrdU, as indicated by 
their low BrdU content (figure 14 A, right panel), suggesting a 
strong reduction or absence of active replication following AKTIP 
downregulation. These data suggest the activation of an intra-S 
checkpoint in AKTIP KD HPFs (Branzei, 2009).  
The strong reduction of active replication in HPFs following 
AKTIP downregulation indicated by FACS analysis was further 
confirmed by cytological analysis of untreated or mild detergent 
extracted cells, as described above, immunostained with an anti-
PCNA (Proliferating Cell Nuclear Antigen) antibody. PCNA is a 
constituent of replication fork and it’s important for the elongation 
phase of replicative process; recent findings suggest that this 
protein has a crucial importance for the control and regulation of 
DNA replication (Moldovan, 2007). In unextracted cells anti-
PCNA immunostaining revealed its nuclear localization during all 
interphase (figure 14 B, on the left). We couldn’t find any 
significant difference in PCNA positive cells frequency between 
control cells and AKTIP KD HPFs analyzed ten days post 
transduction (figure 14 C) suggesting that AKTIP downregulation 
didn’t affect nuclear PCNA localization. Instead following mild 
detergent extraction, that eliminates soluble proteins, anti-PCNA 
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immunostaining allows to visualize only chromatin bound PCNA 
molecules that are part of active replication forks (Chagin, 2010). 
Therefore in this experimental conditions PCNA positive cells are 
S-phase cells with fully competent replication forks. 
Immunostaining with anti-PCNA antibody following detergent 
treatment revealed that, ten days post transduction, AKTIP 
downregulation strongly reduced the proportion of PCNA positive 
cells compared to controls (11% in AKTIP KD HPFs in 
comparison to 25-30% of control cells) (figure 14 D).  
Moreover, as mentioned before, following detergent extraction 
PCNA marks replication foci allowing to visualize their positions 
that change during replication progression: early S-phase is 
characterized by a high number of small foci distributed in the 
internal part of the nucleus; mid S-phase is characterized by a 
reduction of replication foci number and by a switch in their 
localization from the interior of the nucleus to the peripheral part; 
finally late S-phase is characterized by an increase in the 
dimension of replication foci that assume also a more irregular 
shape and are distributed both at nuclear periphery and scattered 
throughout the interior part of the nucleus (examples are reported 
on the left of figure 14 E) (Dimitrova, 2002; Chagin, 2010). Thus 
replication foci nuclear distribution reflects the stage of S-phase 
progression (Chagin, 2010) and we have exploited PCNA 
immunostaining in extracted cells to identify which proportion of 
S-phase cells is in each stage of S-phase. In asynchronous control 
cells most of PCNA positive cells had a pattern compatible with 
early S-phase (figure 14 E); this finding is in agreement with 
previous report that indicates this stage as the longest in primary 
cells (Dimitrova, 2002). AKTIP downregulation triggered an 
altered distribution of PCNA positive cells in the different S-phase 
stages, with a significant (p<0.05) reduction of early S-phase cells 
and a corresponding increase of mid and late S-phase cells (figure 
14 E). 
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Figure 14: AKTIP downregulation impairs proper DNA replication. 
(A): LV-ctr and LV-shAKTIP transduced asynchronous HPFs, 10 days p.i., were FACS 
analysed for PI and BrdU incorporations. Combining these two parameters, percentage of 
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cells in each stage of cell cycle was determined and is reported in the upper part of figure. 
(B): IF with anti PCNA (red) antibody of untreated (left part of the panel) or Triton X-
100 extracted (right part) untransduced (mock) or transduced with the indicated 
recombinant lentivectors HPFs, 10 days p.i. DNA was stained with DAPI (blue). (C-D): 
percentage of PCNA positive cells either in untreated (C) or in Triton extracted (D) HPFs 
is reported. In D samples were analyzed in duplicate and the mean value is presented; p 
value was based on Student t-test and statistical analysis was obtained comparing sample 
values with both controls values (p< 0.05: (*)). (E): analysis of distribution of PCNA 
positive cells in S-phase stage (early S-stage in black, mid S-stage in green and mid/late-
late S-stage in red) reported on left (for description refer to text) is reported. Samples 
were analyzed in duplicate and the mean value is presented; p value was based on Student 
t-test and statistical analysis was obtained comparing sample values with both controls 
values (p< 0.05: (*)).  
 
 
 
Collectively these data suggest that normal replication is impaired 
following AKTIP downregulation, strongly enforcing its functional 
involvement in this cellular process. 
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DISCUSSION 
 
Data presented in this work demonstrate that AKTIP is a new 
telomeric protein. Indeed AKTIP/Ft1 downregulation triggers the 
formation of a characteristic telomeric phenotype that shares some 
similarities with those deriving by un-functional telomeric 
proteins. AKTIP downregulation induces the formation of TIFs 
and the frequency of cells TIFs positive and also the mean number 
of TIFs per cell are comparable to those induced by the presence of 
aberrant TRF2 (Takai, 2003). Moreover, Ft1 downregulation 
results in the formation of different types of telomeric aberrations. 
Most of them were already described as part of the aberrant 
phenotype deriving by KD/KO either of shelterin proteins such as 
TRF1 (Sfeir, 2009; Martinez, 2009) or Rap1 (Martinez, 2010) and 
of telomeric accessory proteins such as Apollo (Ye, 2010), or ATR 
(Pennarun, 2010). So our data indicate that AKTIP is important for 
telomeres maintenance and although it remains to clarify which is 
the molecular function of AKTIP in telomeres metabolism, our 
data strongly suggest that it could be more important for their 
proper semi-conservative replication than for their protection. 
Indeed, among Ft1 KD induced telomeric aberrations, the most 
prominent (MTS and STA) were recently demonstrated to be 
caused by telomeric semi-conservative replication defects (Sfeir, 
2009; Martinez, 2009; Martinez, 2010; Ye, 2010, Pennarun, 2008; 
Pennarun, 2010). Moreover, although we observed a significant 
increase of chromosomal telomeric-fusions following Ft1 
downregulation, their frequency is lower than that caused by KO of 
TRF2 shelterin that has a principle role in telomere capping (Celli, 
2005). AKTIP telomeric role is further corroborated by its 
interaction with telomeric DNA that we observed by ChIP assay 
both in HPFs and in HeLa cell line. This interaction could be direct 
or indirect, and further experiments are needed to determine if 
AKTIP binds telomeric repeats or if this interaction is mediated by 
the interaction of AKTIP with another telomeric protein, shelterin 
or nonshelterin, that can form a bridge between AKTIP and 
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telomeric DNA. Despite of this interaction AKTIP doesn’t co-
localize with TRF1, indicating that AKTIP is not stably and/or 
abundantly located at telomeres; its interaction, directly or 
indirectly, with telomeric repeats, for example, could be cell-cycle 
modulated, but further experiments are needed to clarify this point. 
This last finding, in combination with the telomeric role of AKTIP, 
suggests that it has to be considered as an accessory telomeric 
protein. Indeed, this group of proteins are not constituently 
associated to telomeres even if they are essential for proper 
telomere maintenance (Palm, 2008). Moreover also the existence 
of an AKTIP Drosophila homologue, peo, confirms its 
classification as a telomeric accessory protein because shelterin 
proteins don’t have homologues in this model organism and, 
similarly, also the terminin proteins don’t have homologues in 
human cells. On the contrary telomeric accessory proteins are 
largely conserved between human and flies and for most of them 
also their telomeric function is conserved (Raffa, 2011). The 
finding of a telomeric role for AKTIP enforces the idea that, apart 
from the different elongation mechanisms, Drosophila and human 
telomeres are not so different and AKTIP is the first human 
telomeric protein identified starting from the identification of a 
nonterminin protein in fly. For this reason this work confirms that 
Drosophila can be a good model organism also in telomeres 
biology field and the identification of other nonterminin telomeric 
proteins may lead to the identification of new human telomeric 
proteins. 
In addition to its telomeric function, as the other telomeric 
accessory proteins, AKTIP could have a more general role in 
cellular metabolism and our data suggest that it’s important for 
genomic stability maintenance. Indeed we have observed that 
AKTIP/Ft1 downregulation affects DNA stability also at a more 
general level as suggested by the increased frequency of 
chromosomal breaks and gaps following Ft1 reduction and by the 
increased sensitivity to low doses-aphidicolin treatment of AKTIP 
KD HPFs. Moreover, the presence of extra-telomeric chromosomal 
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aberrations can account for the 50% of observed DNA damage foci 
that don’t co-localize with TRF1. These chromosomal aberrations, 
both telomeric and non-telomeric, trigger the DNA damage 
response that is activated following AKTIP downregulation and 
that, in turn, induces the cell cycle block and proliferation arrest 
observed in AKTIP KD HPFs.  
We hypothesize that AKTIP downregulation could induce these 
chromosomal aberrations impairing proper DNA replication. We 
have obtained data indicating that AKTIP could be involved in 
DNA replication: a) among Ft1 KD induced telomeric aberrations 
the most prominent (MTS and STA) were recently demonstrated to 
be caused by telomeric semi-conservative replication defects 
(Sfeir, 2009; Martinez, 2009; Martinez, 2010;Ye, 2010, Pennarun, 
2008; Pennarun, 2010); b) AKTIP KD increased the sensitivity to 
aphidicolin, a drug that, inhibiting DNA polymerases, slows down 
(in our experimental conditions) or arrest DNA replication; c) 
AKTIP downregulation impaired cell cycle progression blocking 
cells in S-phase, as demonstrated by FACS analysis, and affected 
DNA replication as shown by the reduction of the proportion of 
cells with fully competent replication forks and by the alteration of 
S-phase stage progression following AKTIP downregulation; d) 
AKTIP nuclear localization recalls the position that replication foci 
assume in mid-late S when they reach the peripheral portion of 
nucleus hosting most heterochromatin (Dimitrova, 2002; Chagin, 
2010). Moreover, AKTIP structurally belongs to UEV proteins 
family and, as a member of this family, it could be involved in 
regulative ubiquitilation, a post-translational modification that is 
important for DNA replication control and regulation especially 
when the replication fork encounters problems (Moldovan, 2007; 
Branzei, 2009). Although it has to be determined if AKTIP could 
act mechanistically as an UEV protein and eventually which could 
be its target(s), its putative UEV function suggests that AKTIP 
could be important for the proper replication of specific regions of 
the genome that require particular attention. For these reasons our 
current hypothesis is that AKTIP could be necessary for the 
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stability or the progression of replication fork particularly at 
“replication challenging” sites, often late replicating regions, such 
as repetitive DNA, or at DNA with secondary structures or 
topological alterations to solve. The eukaryotic genome contains 
numerous natural impediments to replication that, during 
unperturbed S-phase, can induce the pausing or completely block 
the replication forks progression, increasing the odds for 
replication fork breakage events (Branzei, 2010). Telomeres are 
part of this group of “replication challenging” genomic regions and 
a lot of questions about their semi-conservative replication remains 
to be solved. (Gilson, 2007; Sampathi, 2011). Our data indicate 
that AKTIP is important for telomere replication, although further 
experiments are needed to understand which molecular function 
AKTIP could play in this process. Moreover our data suggest also 
that AKTIP could be important for the stability of fragile sites, that 
are other genomic regions characterized by a difficult replication. 
This last finding not only contributes to corroborate the idea that 
telomeres could resemble fragile site (Sfeir, 2009) but also 
enforces our hypothesis that AKTIP could be important for the 
replication not only of telomeres but also of other genomic regions 
sharing some features with telomeres, such as the possibility of 
forming secondary structures needing of unwinding during 
replication or the presence of proteins tightly bound to DNA.  
AKTIP localization in the nucleus, with its high enrichment at 
nuclear periphery, could also support the hypothesis of its 
involvement in handling of dangerous or problematic genome 
regions. Growing evidences underline that chromatin is not 
randomly distributed in the nucleus and support the existence of a 
higher level of organization, known as nuclear architecture, that 
basing on positioning of chromatin regions and other nuclear 
components into 3D nuclear space, allows to organize and regulate 
the different nuclear functional processes (Misteli, 2011; 
Gonzalez-Suarez, 2008; Misteli, 2007). Different genome regions 
occupy specific territories in the nucleus (interphase chromosome 
territories); gene-poor domains are often found at the nuclear 
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periphery, while gene-rich territories tend to localize at the nuclear 
interior. However, chromosome territories are not static, but rather 
dynamic structures, and, for example, it has been shown that 
specific chromosomal regions can occupy different nuclear 
positions in cells from different tissues or from different 
developmental stages and their different positions correlate with 
their expression status (Misteli, 2011; Gonzalez-Suarez, 2008; 
Misteli, 2007). According to this model, nucleus is 
compartmentalized and nuclear periphery appears as a specialized 
zone with proper features that enable it to host and manage most of 
transcriptionally inactive genomic regions or most of late-
replicating heterochromatin (Tam, 2004; Misteli 2011).  
Several evidences indicate that telomeres interact with nuclear 
envelope. In budding yeast, telomeres are clustered to nuclear 
envelope and this localization is associated with transcriptional 
repression (Gartenberg, 2009; Akhtar, 2007). In yeast also 
unrepaired or slowly repaired ds-breaks are tethered to nuclear 
periphery (Nagai, 2008; Oza 2009; Gartenberg 2009; Oza, 2010) 
strengthens the idea that nuclear periphery is a subcompartment to 
handle genomic hazardous regions. Although mammalian 
telomeres cluster at nuclear periphery only during meiosis, 
abundant evidences indicate that they interact with nuclear matrix 
(de Lange, 1992; Luderus, 1996). Telomeres in budding yeast are 
replicated in concert late in S-phase (Friedman, 1995), whereas the 
bulk of mammalian telomere sequence is replicated through S-
phase (Wright, 1999). It has been demonstrated that each telomere 
replicates in a specific moment of S-phase independently from its 
length; the replication time of each telomere correlates with its 
nuclear position: more peripheral is the telomere in the nucleus, 
later it replicates. These findings strengthen the link between 
replication timing and high order genome organization (Arnoult, 
2010). AKTIP with its peculiar accumulation at nuclear rim could 
be accumulated where the “replication challenging” genomic 
regions were processed likely contributing to their handling. 
Further studying on AKTIP role in DNA replication could 
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contribute to enforce the nuclear architecture model and the 
importance of subnuclear compartmentalization for cellular 
metabolic processes.    
The nuclear matrix in higher eukaryotes is formed essentially by 
nuclear lamina and by internal fibrogranular network (Nickerson, 
2001) and has a crucial role in nuclear architecture maintenance 
(Gonzalez-Suarez, 2008; Misteli, 2011). In mammals the nuclear 
lamina is constituted mainly by two types of lamins: B-type 
lamins, which are constitutively expressed in most tissues, and A-
type lamins, which are developmentally regulated and mainly 
expressed in differentiated cells. The main function of the nuclear 
lamina is to provide a scaffold for multiple protein complexes that 
regulate different nuclear functions, including transcription, 
replication, and DNA repair (Hutchison, 2004; Broers, 2006; 
Dechat, 2010). It also helps to maintain cell integrity and nuclear 
shape, in addition to serve as an anchor for chromatin at the 
nuclear periphery (Gonzalez-Suarez, 2008). The importance of 
nuclear lamins in the integration and coordination of the different 
nuclear processes become evident analyzing the aberrant 
phenotype deriving by mutations in lamin A encoding gene 
(LMNA). A lot of different pathologies, collectively called 
laminophaties, are associated with mutations in LMNA gene, some 
of which associated with muscular dystrophy (Goldman, 2002). 
Cellular and/or organismal models of these pathologies show 
defects in chromatin remodelling and in 3D organization of the 
genome, as exemplified by loss of heterochromatin from nuclear 
periphery (Capell, 2006; Shumacker, 2006; Coutinho, 2009). One 
of the most severe laminophaty is the Hutchinson Gilford Progeria 
Syndromes (HGPS) that it’s caused by LMNA mutations 
generating a truncated version of lamin A (de Sandre-Giovannoli, 
2003), called progerin, which lead to premature senescence 
(Goldman, 2004). Although the molecular pathogenic mechanisms 
are still poorly understood, growing evidences underline that 
genomic instability and dysfunction in telomere maintenance play 
a crucial role in premature aging syndromes. Telomeres of HGPS 
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fibroblasts were shown to undergo faster telomere attrition during 
proliferation than normal counterparts (Allsopp, 1992; Huang, 
2008) and also telomeres from a mouse model of the disease are 
consistently shorter than controls and exhibit an increase in signal 
free ends (Gonzalez-Suarez, Redwood, Perkins, 2009). Moreover 
also the 3D positioning of telomeres is altered in Lamin A null 
mice (Gonzalez-Suarez, Redwood, Perkins, 2009) and, 
interestingly it results affected also in tumour cells  (Mai, 2006) 
and in senescent cells (Raz, 2008). Moreover, cellular defects 
associated with HGPS include a reduced lifespan in culture and 
premature senescence, irregular nuclear shape, altered chromatin 
organization, a chronic DNA damage response activation and 
genomic instability (Musich, 2009; Benson, 2010; Gonzalez-
Suarez, Redwood, Gonzalo, 2009; Liu, 2008). Very little is known 
about the molecular mechanisms that underlie this complex 
diseases and our data suggest that AKTIP could be involved in 
laminopathies and in particular in progeroid syndromes. We have 
observed that AKTIP co-localizes with lamin B1 suggesting the 
possibility that it could be a new lamins interactor, and further 
experiments investigating AKTIP-lamins interaction, direct or 
indirect, can clarify this point. Moreover, some phenotypic traits of 
HGPS cells overlap with AKTIP KD phenotype, such as the 
induction of premature senescence, an high incidence of 
chromosomal aberrations, alteration in telomere maintenance, the 
activation of a DNA damage response in absence of genotoxic 
stress. Also for HGPS cells has been hypothesized that 
chromosomal aberrations observed can be linked to replication 
problems that may lead to stalled replication forks; their collapse 
could result in ds breaks formation (Musich, 2009). It will be 
interesting to analyze if AKTIP quantity or localization could be 
altered in progeroid cells and further information about AKTIP 
putative involvement in progeroid syndromes could come from the 
analysis of Ft1 KO mice that we are currently generating. 
Additional study on AKTIP protein could help to find a connection 
between aging, lamins and telomere maintenance.    
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MATERIALS AND METHODS 
 
Cells and virus 
 
Human foreskin primary fibroblasts (HPF) from healthy donors 
(provided by A. Orecchia, IDI, Rome, Italy) were used, unless 
otherwise indicated, at early passages (5-11). HPFs, p53-/- MEF 
(provided by S. Soddu, IFO, Rome Italy), HPF, HeLa (ATCC 
CCL-2) and 293T (ATCC CRL-11268) cells were cultured in 
DMEM (Invitrogen) supplemented with 10% FBS (Invitrogen). 
Second generation recombinant lentiviruses (LV) were produced 
and titrated as already described (Piersanti, 2006) by co-
transfection of 293T cells with the vectors pCMV-dR8.74, 
pMD2.G (http://www.addgene.org), and a transfer vector encoding 
gene specific interfering sequences (Table I). The transfer vectors 
were PLKO.1 (Sigma). Lentivectors produced were titrated 
measuring p24 concentration per ml of viral production as 
described (Piersanti, 2006). The moi (molteplicity of infection 
measured as p24 pg per cell) used for all the experiments was 3 for 
human cells transduction and 10 for mouse cells. Transductions 
were performed in complete medium supplemented with 8 µg/ml 
polybrene (Sigma). After viral addition, cells were centrifuged for 
30' at 1800 rpm at RT, incubated 3h at 37°C, and then transferred 
to fresh complete medium. 72h post transduction, cells were 
subjected to selection in complete medium supplemented with 
2µg/ml puromycin (Sigma) and kept under these conditions for 
further analyses. 
Population doubling (pd) was calculated according to the following 
formula: Log (nt/n0) x 3.33, where nt is the cell number in the n 
day post transduction and n0 is number of cells plated; the 
cumulative pd are represented. 
Cell irradiation with X-rays (Gilardoni MGL 200/8D, 0.2 mm 
copper filtration, 200KVp, 6mA) with 1Gy (42 cm, 0.28 Gy/min) 
was performed where indicated.  
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AKTIP-Flag protein was transiently expressed in 293T cells using 
a Calcium Phosphate transfection with the plasmid pCMV6-Entry 
encoding the Flag tagged protein (OriGene, NM_001012398). 
 
 
 
Table I: Interfering sequences encoded by transfer vectors used to produce 
recombinant lentivectors. Name, sequence target gene and position of target sequence 
are indicated for each interfering sequences encoded by transfer vectors used to produce 
recombinant interfering lentivectors employed in this work.  
 
 
 
Gene expression  
 
Cells were lysed one-week post transduction by addition of TRIzol 
reagent (Invitrogen) and RNA extracted according to the 
manufacturer's instructions. After DNase treatment (Invitrogen), 
RNA was reverse transcribed into cDNA with oligo d(T) primer 
and OMNISCRIPT RT KIT (Qiagen). To quantify target gene 
expression, specific primers (Table I) were selected using Primer 
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Express software (Applied Biosystems). Reactions were performed 
as previously described (Piersanti, 2006). 
 
Senescence associated β-galactoside staining  
 
At the indicated time post transduction, 24h after plating on 
coverslips cells were assayed for senescence associated β-
galactosidase (SA-β-GAL) as previously described (Dimri, 1995), 
using the Senescent cells Histochemical Staining Kit (Sigma). 
Images were taken using a Zeiss Axiophot microscope equipped 
for differential interference contrast microscopy. 
 
Immunoblotting 
 
Cell pellets were treated with lysis buffer [Tris–HCl 50mM pH7.4, 
10% NP-40, 0.25% NaDesoxycholate, EDTA 1mM, NaCl 150mM, 
PMSF 1mM, protease inhibitor cocktail (Roche)]. Samples were 
loaded on to pre-cast 4–12% gradient acrylamide gels (NuPAGE, 
Invitrogen). After electro-blotting, filters were incubated with the 
following antibodies: anti-AKTIP (Sigma), anti-b actin-HRP 
conjugated (Santa Cruz Biotechnology), anti-cyclin A (Santa Cruz 
Biotechnology), anti-cyclin B (Santa Cruz Biotechnology), anti-
cyclin E (Upstate Biotechnology), anti-p53-pSer15 (Cell Signaling 
Technology), anti-p53 (DakoCytomation), anti-ATM-pS1981 
(Rockland Immunochemicals), anti-ATM (Genetex), anti-ChK1-
PSer 345 (Cell Signaling Technology). Filters were then incubated 
with corresponding secondary antibodies HRP-conjugated 
(SantaCruz Biotechnology). Immunoreactive proteins were 
revealed using the enhanced chemiluminescence system (ECL 
plus, Amersham). Where indicated quantification was obtained 
valuating bands intensity with Image J software (developed by 
National Institute of Health (USA)); bands intensity was 
normalized using corresponding loading control (bactin) bands 
intensity. 
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Immunofluorescence  
 
At the indicated time points post transduction, after plating on 
coverslips, cells were fixed with 3.7% formaldehyde 10’ at 4°C, 
and permeabilized with Triton X-100 0.25% in PBS 1’. For 
immunoblotting with anti PCNA antibody after formaldehyde 
fixing the cells were treated with cold methanol for 5’ at RT 
followed by PBS washes. Where indicated, a pre-permeabilization 
fixing protocol was performed as previously described (Zhu, 
2000). The cells were then blocked with BSA 3% and incubated 
with the following primary antibodies: anti-ATM-pS1981 
(Rockland Immunochemicals), anti-53BP1 (Novus Biologicals), 
ant-gH2AX (Upstate Biotechnology), anti-AKTIP (Sigma), anti-
FLAG (SIGMA), anti-Lamin B1 (Santa Cruz Biotechnology), anti-
PCNA (Santa Cruz Biotechnology) and anti-TRF1 (provided by T. 
de Lange, Rockefeller University NY). Cells were incubated 45’ at 
RT with secondary antibodies FITC- (Jackson Immunoresearch) or 
ALEXA 555- (Invitrogen) or RODHAMINE- (Jackson 
Immunoresearch) conjugated. After drying, cells were mounted on 
glass slides with DAPI-Vectashield (Vector laboratories). Slides 
were analyzed with a Zeiss Axioplan epifluorescence microscope 
equipped with a cooled CCD camera (Photometrics); the signals 
recorded as grey-scale digital images were pseudo-coloured using 
Adobe Photoshop. In alternative, where indicated, slides were 
analyzed using a calibrated Prior Proscan stepping motor, with an 
EM-CCD camera (Cascade II, Photometrics) connected to a 
spinning-disk confocal head (CarvII, Beckton Dickinson) mounted 
on an inverted microscope (Nikon). Images were acquired using 
Metamorph software package (Universal Imageing). Eight 
fluorescence optical sections were captured at 1µm Z steps and the 
images of the different sections were analyzed separately or, when 
indicated, the images shown are a maximum-intensity projection of 
all the sections. 
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FISH and metaphase spread analyses 
 
For mitotic index determination metaphase spreads obtained from 
HPFs were analyzed: 24h after plating on coverslips, cells were 
incubated with colchicine (Sigma) for 3h, then treated with 
hypotonic solution (KCl 75 mM) for 7’at 37°C and fixed with 
Methanol: Acetic Acid 3:1 for 15’ at RT. After drying, cells were 
mounted on glass slides and, treated with DAPI-Vectashield 
(Vector Laboratories). Mitotic Index was considered as the ratio 
between metaphase number and the total number of cells counted. 
For the evaluation of aphidicolin-induced breaks and gaps, HPFs 
transduced as indicated, ten days post transduction were treated as 
described above following 24h incubation with 0.4 µm aphicolin 
(Sigma) in culture medium. Chromosomal aberrations were 
evaluated on DAPI-stained metaphases. 
For FISH assay the hybridization was carried out on metaphase 
spreads obtained from p53-/- MEFs, transduced as indicated, one 
week post transduction and after 30’ of incubation with colchicines 
in plates; the cells were then trypsinized and collected by 
centrifuge; then were treated with hypotonic solution (KCl 75 mM) 
for 20’ at RT and fixed by treatment 3 times with Methanol: Acetic 
Acid 3:1 for 2h at 4°C. The suspension obtained in this way was 
then dropped on cold wet slides. The slides were air-dried for one 
week at RT; then were dehydrated by successive ethanol baths and 
air-dried again. Following treatment for 50’ at 65°C the DNA was 
denatured by heat for 1’30’’ at 80°C and dehydrated as described 
above and air-dried again. The probe was obtained by a PCR 
reactions carried out in absence of template using primers 
(TTAGGG)5 and (CCCATT)5 (Operon) as described (Ijdo, 1991). 
The PCR reaction was performed in presence of 200 µM of 
dATP/dCTP/dGTP, 130 µM of dTTP and 70 µM of DIG-dUTP 
(PCR Dig Probe Synthesis Kit, Roche). The PCR products were 
fragmented by sonication (2 times for a 10’’ pulse at 50% power 
setting using a Braun Biotec-Sartorius ultrasonicator equipped with 
a 2 mm tip) to reach a 500 bp-2000 bp of length. The probe was 
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denatured by heat for 8’ at 80°C in the hybridization buffer 
[Formamide 50%, SSC 2X and dextran sulfate 50%] and was 
added to the slides; the hybridization was carried out at 37°C for 
16-18h. Following 3 washes in SSC 1X at 60°C, the slides were 
incubated for 30’ at 37°C in the blocking solution [BSA 30 mg/ml, 
SSC 4X, TWEEN-20 0.1 %] and then with the anti-DIG antibody 
(Roche, 10 mg/ml) in the detection buffer [BSA 10 mg/ml, SSC 
1X, TWEEN-20 0.1 %] for 30’ at 37°C. The slides were then 
washed 3 times in SSC 4X-TWEEN-20 0.1% and air-dried. After 
drying the cells were treated with DAPI-Vectashield (Vector 
Laboratories).The slides were analyzed using a Zeiss Axioplan 
epifluorescence microscope as described above. Telomeric 
aberrations scored were essentially: chromosomes with telomeric 
signal free ends, sister telomere association, multiple telomeric 
signals, fragments with one or more telomeric signals, 
chromosomes with extratelomeric signals, interchromosomal 
fusions with or without telomeric signal at fusion point. 
For the detection of chromosomal aberrations in MEFs transduced 
as indicated, cells were treated as described above and breaks and 
gaps were observed on GIEMSA-stained metaphases. 
 
ChIP 
 
For ChIP assays HPFs and HeLa cells were cross-linked adding 
formaldehyde at a final concentration of 1% directly into the 
culture medium for 15’ on a shaking platform; the reaction was 
stopped by adding glycine at a final concentration of 0.125 M. The 
cells were then scraped and lysed and chromatin was extracted as 
previously described (Benetti, 2008). Chromatin fragments 
obtained were incubated with 7.5 mg of mouse monoclonal anti-
AKTIP antibody (Sigma) or 1 ml of mouse IgG (Sigma) at 4°C 
overnight on a rotating platform. Then Salmon Sperm 
DNA/protein agarose beads (60ml) were added and incubated for 
1h at 4°C. Immunoprecipitation and following cross-linking 
reversal and DNA extraction were carried out as previously 
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described (Benetti, 2008). DNA obtained in this way was slot-
blotted into a Hybond N+ and hybridized with a telomeric probe 
obtained from a plasmid containing a 1.6 kb of TTAGGG repeats 
(gift from T. de Lange, Rockefeller University, USA) and with an 
Alu probe obtained by genomic DNA amplification using the 
following oligos: sense 5’-CGCCTGTAATCCCAGCACTTTG-3’, 
antisense 5’-ACGCCATTCTCCTGCCTCAGC-3’ (MWG-
Biotech). The quantification of the signal was done using a 
ImageQuant Software.  
 
Southern blotting 
 
For genomic DNA isolation ten millions of untrasduced, LV-ctr 
and LV-shAKTIP transduced HPFs, thirteen days post transduction 
and of late passage (30) untreated HPFs were harvested by 
trypsinization washed with cold PBS and collected by 
centrifugation at 1000 rpm for 5’. Then the genomic DNA was 
isolated with NucleoSpin Tissue Genomic DNA Isolation Kit 
(Clontech). Three µg of genomic DNA for each sample were 
cleaved with Hinf I/Rsa I (Roche) and separated in a 0.7% agarose 
gel. The fractionated DNA was depurinated by treatment with HCl 
0.25 M for 20’, denaturated by treatment with NaCl 1.5M – NaOH 
0.5M for 40’ and neutralized in NaCl 1.5M – TrisHCl 0.5M ph 7.5 
for 40’. The DNA was then transferred in Nytran-N membrane 
(Whatman) in 20x SSC (NaCl 3M, sodium citrate 0.3M ph 7) over 
night. The membrane was backed at 80°C for 2h and then 
hybridization has done using DIG Luminescent detection Kit 
(Roche) and a TTAGGG repeats probe over night at 47.8°C. The 
probe was obtained as described above. After hybridization low 
stringency washes were performed using SSC 2X-SDS 0.1% at 
room temperature (two washes for 5’) and high stringency washes 
were performed using SSC 0.2X - SDS 0.1% at 50°C. The 
following incubation with an anti-DIG antibody and the revelation 
reaction were carried out using DIG Luminescent detection Kit 
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(Roche) according to the manufacturer instructions. Final 
revelation was obtained by exposition on Hyperfilm (Amersham). 
 
Flow cytometry analysis of cell cycle distribution.  
 
5-bromo-deoxyuridine (BrdU) at the final concentration of 45 µM 
was added to the culture medium 30 min before harvesting the 
cells. Cells were fixed in 70% ethanol (30 min, 4°C), washed twice 
in PBS + 0.5% Tween 20 and incubated in 3M HCl for 45 min. 
Cells were then exposed to anti-BrdUrd monoclonal antibody 
(Dako), to the secondary Alexa-Fluor488-conjugated antibody 
(Jackson) and counterstained with Propidium Iodide (PI, Sigma) 20 
µg/ml. Acquisition was carried out using a Beckman-Coulter Epics 
XL flow-cytometer and recorded data were analyzed by the 
WinMDI software (developed by Joe Trotter, free download at 
http://en.bio-soft.net/other/WinMDI.html). 
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